M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
THE ADVANCEMENT OF HUMAN LIFE SCIENCE IN WALES
SUPPORTED BY THE WELSH GOVERNMENT
ANNUAL REVIEW AND DIRECTORY 2014-15
1
Y O U R
S T E R I L E
S I N G L E - U S E
S O L U T I O N
W I T H O U T
C O M P R O M I S E
thesummary
Once used. Workflow improves. 4%
W E L S H L I F E S C I E N C E S E C TO R S DATA
3%
25%
19%
®
C O M PA N I E S BY S E C TO R
2 t +44 (0) 1792 797 910 e info@dtrmedical.com w www.dtrmedical.com
MEDICAL TECHNOLOGY AND DIAGNOSTICS
5%
MEDICAL BIOTECH
5%
INDUSTRIAL BIOTECH
71%
PHARMACEUTICALS
SUMMARY
E M P LOY M E N T L E V E L S
68%
Visit us at Hall 16 F42
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
A message from MediWales MediWales is the Life Science Network for Wales - supporting over 150 members from the medical technology, diagnostic and pharmaceutical industries, the NHS Health Boards and University departments. We run a very popular programme of events which focus on important strategic issues, including the UK procurement landscape, finance and funding, unmet clinical needs, international trade and regulation. Throughought the calendar year our special interest groups and themed events help support our members, encourage collaborations and promote the lively Welsh life science sector on both the national and international stage. Highlights in the MediWales calendar include our highly acclaimed UK HealthTech conference and our prestigious Annual Innovation Awards and Dinner which is the perfect get-together to celebrate the achievements of our companies and NHS colleagues. Our MediWales Annual Review and Directory provides you with a summary of the successes of the past year as well as an overview of the thriving Welsh life science sector. With turnover increasing to over £2 billion, this industry is a significant part of the Welsh economy. Our events calendar features the key conferences, trade shows and missions taking place both nationally and internationally to help you successfully plan your year. Useful contacts for business support, funding and international trade can be found on our ‘organisations of interest’ page. A comprehensive directory provides an easily accessible listing of our members in medtech and diagnostics, pharmaceutical services, NHS, contract and testing, professional services, university departments and charities. An invaluable source of information for those in the life science community.
4
14 19
Advancement of Human Life Science in Wales
7
10 12
Organisations of Interest
The Team
MediWales’ Annual Review Summary
MediWales’ Performance
thecontents
Introduction Directory 20 Members
The Life Science Advisory Forum
58
Life Science Event Calendar
A big thank you to our board of directors and sponsors Abel and Imray, Geldards LLP, GX Group and Elite Electronic Systems as well as to our University Partner Swansea University for all of their help and support. Importantly, MediWales also continues to be part-funded by Welsh Government.
7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ Tel: +44 (0)29 2047 3456 Web: www.mediwales.com
Gwyn Tudor, Forum Manager: gwyn.tudor@mediwales.com
Julie Alcock, Project Manager: julie.alcock@mediwales.com
Debbie Laubach, Operations Manager: debbie.laubach@mediwales.com
Tess Coughlan-Allen, Communications Manager: tess.coughlan-allen@mediwales.com
Lucinda Scott-Morgan, Publications and Editorial Manager: lucinda.dargavel@mediwales.com
Thank you to our Corporate Sponsors and University Partner
G
R
U
P
MEMBER
3
MediWales Directory designed by Teamworks www.teamworksdesign.com SUPPORTED BY THE WELSH GOVERNMENT
the themission summary
Advancement of Human Life Science in Wales E M P LOY M E N T L E V E L S
This year MediWales will work to: l maintain l support
a high level of support for the life science sector
our members to trade successfully both in the UK and abroad
4%
l maintain
in Wales
W E L S H L I F E S C I E N C E S E C TO R S DATA
opportunities for organisations to promote their products and services, 3% to seek collaborative partners and to share good practice and concerns
l create
detailed, up to date, market intelligence about the life science sector
l improve
access to markets and clinical expertise, for the life science sector in Wales, for the benefit of patients and the economy
l ensure that the
celebrated
25%
profile of Wales to UK and international audiences as a leading place for life science business
Structured for successful delivery, our six pillars are:
Communications promoting the Welsh life science community in Wales and beyond
Market Intelligence
facilitating access to vital clinical expertise and facilities
5%
The advancement of Human Life Science in Wales 19%
5%
Advocacy
MEDICAL BIOTECH
Clinical Access
Recognition
INDUSTRIAL BIOTECH
PHARMACEUTICALS
the primary source of essential sector knowledge
engaging with Government to align support with sector needs
C O M PA N I E S BY S E C TO R
4
71%
MEDICAL TECHNOLOGY AND DIAGNOSTICS
THE MISSION
l raise the
successes of the Welsh life science sector are publicised and
celebrating success across the life science community
Trade Support access to global trade opportunities
68%
M M EE D D II W WA A LL EE SS
R R EE V V II E E W W
This year’s UK HealthTech Conference will announce the launch of “Clinical Trial Services Wales.” The objective of this group is to improve both M the E D profile I W A Land E S reputation A N N U A of L R E V I E W our pharmaceutical cluster and demonstrate that it is a significant and sophisticated delivery partner with which to undertake the clinical trials.
thecontents International Trade:
4
International trade has become an increasingly vital part of life science business in Wales. Whether that be with the more established markets of Europe and the US, the BRIC countries of Brazil, Russia, India and China or Advancement the United Arab Emirates; MediWales of Human Life actively supports international Science in Wales missions through its presence at Medica, Bio San Diego, Arab Health and CPhI, as well as bringing international trade partners to MediWales’ Wales for briefings Annual Review and events.
10 11 12 Recognition
Summary
Although based in Wales, MediWales maintains a UK voice through strong Structure and relationships with the Association of BritishManagement Healthcare Industries, UK Trade and Investment, BioIndustry Association, Scottish Enterprise and the Knowledge Transfer Network as well as connections to Academic Advisory Health Science Networks Group nationwide. Our involvement with Medilink UK is cemented through the production of our national publication UK Lifescience Industry Magazine.
Our cluster is capable of delivering a full clinical trials service including formulation, analytical services, manufacturing, packaging distribution, and through Health Research Wales and the NHS, principal investigators and sites for multi-centre trials and MediWales’ clinical studies.
14 19 20
A A N N D D
D D II R R E E C C T T O O R R Y Y
2 2 0 0 11 4 4 -- 11 5 5
of our life science network to those who are not yet a part of it. It enables us to show not only the depth of our national network Abut N Dalso D Ito R demonstrate E C T O R Y 2 0 1 4 - 1 5 the strong connectivity between organisations that make Wales uniquely well networked across life science.
Performance
One of our strategic objectives is to raise the profile of Wales on both the UK and the international stage and our project ‘Picture of Health’ will be Organisations one of the factors to help us achieve of Interest this. Launched at BioWales 2013, the ‘Picture of Health’ portal allows us to actively illustrateLife Science Event Calendar the strength
22
Life Science Event Calendar
THE MISSION
The MediWales team delivers a core programme of events, produces publications and provides online support and day-to-day assistance to its members. These communications strengthen our relationships within the life science community.
A AN NN NU UA A LL
Introduction
Our MediWales Annual Review and Directory provides you with a summary of the successes of our past year as well as an overview of activity for the whole of the life science sector in Wales. One again, our events calendar highlights the key conferences, trade shows and missions taking place both nationally and internationally to help you successfully plan your year. Useful contacts for business support, funding and international trade can be found on our ‘organisations of interest’ page and our directory puts contacts in industry, NHS (contract & testing), professional services, university departments and charities to hand. Our aim is for this edition to prove an invaluable source of information for those in the life science community. Lucinda Scott-Morgan Editor
Corporate Sponsors MEMBER
5
thesummary
The second UK HealthTech Conference took place on 10th December in the Hilton, Cardiff. Delivered by MediWales the event attracted over 200 professionals, clinicians and industry specialists.
PHARMACEUTICALS
The six seminars produced a thorough look at the landscape of the UK’s medical technology, medical biotechnology, industrial biotechnology and pharmaceutical sectors. These were NICE’s Med Tech briefings, grants for SMEs, clinical access- which showcased the work of Health Research Wales, the Technology Strategy Board’s Biomedical Catalyst Fund, NHS procurement from a UK-wide perspective and the impact of the regulatory changes for medical devices.
6
Consistent collaboration Events provide a perfect platform to nurture interaction and collaboration. They allow for the promotion of the Welsh life science brand, widen the net of potential investors for our members and increase our sources of intelligence. MediWales delivers a full programme of events throughout the year.
This collaborative event with Wales Procurement Services outlined the changes that have been made to the way procurement is now operating as well as the procurement issues colleagues see when tenders are returned. Speakers at the event included Mark Roscrow, Assistant Director of Shared Services – Procurement Services and Andrew Smallwood – Head of Sourcing.
5%
Other funds and programmes featured included i4i, EU Horizon 2020, the Wales Life Sciences Investment Fund managed by Arthurian, the NHS Health Technology Challenge Fund and the support available from Welsh Government.
25%
MediWales’ NHS Procurement Event covered the new NHS procurement arrangements in Wales and included an overview of CCG and procurement in the English NHS.
19%
In June, MediWales’ Finance & Funding event highlighted the latest sources of funding and finance for R&D and clinical trials for clinical collaborations and industry projects. The event focused on exciting new calls in the area of clinical unmet needs for the NHS community such as the Small Business Research Initiative Throughout the day the presentations (SBRI) and Finance Wales’ five-year built up to produce a comprehensive Wales Technology Seed Fund aimed at picture of the health technology market, technology start-ups, university spin including exciting research, new product outs and IP rich companies to help them announcements and the ever-closer products C O M P A N I E Scommercialise B Y S E Ctheir T Oinnovative R collaboration between clinical expertise and technologies and bring them to and industry. While acknowledging that market.
5%
R&D funding can be applied for from the TSB in specific priority areas, as well as non-themed ‘always open’ competitions such as Smart.
71%
Both of these events featured surgeries with the Life Science Exchange.
The Life Science Exchange MediWales partnered with Swansea University, Cardiff University and NISCHR AHSC to help The Life Science Exchange deliver the Welsh Government funded Life Science Wales project. The project enlisted a network of highly specialised groups comprising academia, representatives from industry, the Welsh Government and NHS Wales;
MEDICAL TECHNOLOGY AND DIAGNOSTICS
The plenary sessions covered three key areas: wound healing, regenerative medicine and diagnostics, and the conference concluded with a panel discussion focusing on healthcare future trends which looked to the future of life science and health technology. Chaired by Andy Taylor of the Association of British Healthcare Industries the panel consisted of the days keynote speakers.
there is still much to be achieved to improve the adoption of 3% innovative technologies in healthcare, there was a considerable amount to celebrate.
MEDICAL BIOTECH
The day consisted of presentations, seminars and plenary sessions, with the programme including Professor Keith Harding CBE of the Wound Healing Research Unit, Dr Stephen Minger from GE Healthcare, Professor Julie Williams CBE, Chief Scientific Adviser for Wales and Richard de Souza of Martindale Pharma, as well as guest speaker Tom Pellereau of ‘Apprentice’ fame and Professor Val Edwards-Jones from ‘Embarrassing Bodies.’
E M P LOY M E N T L E V E L S
INDUSTRIAL BIOTECH
4%
W E L S H L I F E S C I E N C E S E C TO R S DATA
THE MISSION
A truly collaborative event, MediWales partnered with the Association of British Healthcare Industries, Medilink UK, the HealthTech and Medicines Knowledge Transfer Network, Med-Tech Innovation, One Nucleus, UK Trade and Investment, the Life Science Exchange and the UK Lifescience Industry magazine to develop the conference, which was supported by Welsh Government, Health Research Wales and The Society of Biology.
Six groups in total focused on the following aspects of the Life Science sector:
68%
l Medical Devices l Regenerative Medicine l Diagnostics l Pharmaceuticals l Neuroscience l eHealth
The aim was to identify the key strengths as well as the barriers to wider collaboration and to focus upon maximising existing opportunities and ways in which greater collaboration can be achieved. The resulting report highlighting the outcomes of this project can now be obtained from Brian Perkins, b.l.perkins@swansea.ac.uk.
theteam Debbie Laubach, Operations Manager: Responsible for project management, memberships, events, the life science advisory group, Pharma Special Interest Group and the clinical access initiatives.
Julie Alcock, Project Manager: Membership services, supporting our events programme and coordinating the Innovation Awards.
Lucinda Dargavel Scott-Morgan, Publications and Editorial Manager: Editor of the MediWales Review and UK Lifescience Industry magazine, Lucinda is also responsible for the editorial of external publications as well as PR services.
Tess Coughlan-Allen, Communications Manager: Member enquiries, promotion and running of regular events, managing digital and social media and organising the UK HealthTech Conference.
A N N U A L
Gwyn Tudor, Forum Manager: Responsible for strategic direction, business planning and representative roles with Welsh and UK bodies.
Mr Greg Baily, Huntleigh, MediWales Chairman
Huntleigh designs, manufactures and globally distributes a wide range of medical devices together with associated software systems. These include fetal monitors, pocket Dopplers, patient monitors, cardiovascular assessment and treatment systems.
Andrew Thomas, Rogue Resolutions, MediWales Company Secretary Rogue Resolutions provides integrated equipment solutions and services within the field of Neuroscience and Neurology brain research. Its partners are Rogue Research Inc and neuroConn GmbH, and together their portfolio of services and products includes a range of ‘best-in-class’ devices.
Professor Paul J Smith, School of Medicine, Cardiff University, MediWales Director Recognised leader in advanced cytometry. Research and innovation in basic cancer biology, molecular probe development, anticancer drug design and technologies for the life sciences sector.
Dr Catherine Ramsay, MediWales Director With 35 years experience in development and commercialisation of rapid testing products with clinical, defence and industrial applications. Formerly working for 3M Food Safety in Bridgend, a leading manufacturer of rapid hygiene testing and microbial screening products.
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Andrew Davidson, DTR Medical, MediWales Director
DTR Medical is leading manufacturer of specialist sterile single-use surgical instruments made to a high quality and supported by exceptional levels of service and which are used widely in the UK NHS and private providers as well as in many overseas markets.
Professor David Ford, College of Medicine, Swansea University, MediWales Director
David Ford is Professor of Health Informatics and leads the Health Informatics Group at College of Medicine in Swansea University. David is Director of the Administrative Data Research Centre (ADRC) Wales, an £8 million investment by the Economic and Social Research Council (ESRC).
THE TEAM
M E D I W A L E S
Dr Paul Michael, GE Healthcare, MediWales Director
GE Healthcare is a world leader in medical diagnostics and life sciences. Focused on enabling molecular medicine, the company works through business areas in diagnostic imaging, protein separations, consumables and cellular technologies.
Chris Williams, Ig Innovations Ltd. MediWales Director
Ig Innovations provides bespoke contract services for antibody production, characterisation, purification as well as point-of-care assay development. The facility serves the research, diagnostic and therapeutic sectors.processing, validation, regulatory and commercial activities.
7
thesummary
Inventing spaces to inspire E M P LOY M E N T L E V E L S collaboration, learning and discovery W E L S H L I F E S C I E N C E S E C TO R S DATA
www.ibigroup.com
4%
3%
25%
19%
MEDICAL TECHNOLOGY AND DIAGNOSTICS
5%
MEDICAL BIOTECH
5%
INDUSTRIAL BIOTECH
PHARMACEUTICALS
71%
68%
Brief Writing. Feasibility. Master Planning. Architecture. Laboratory & Health Planning. Landscape Design. Research & Development. Town Planning. Interior Design. BREEAM / LEED.
C O M PA N I E S BY S E C TO R
Specialising in science, healthcare and education environments.
8
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
PICTURE OF HEALTH
Unrivalled connectivity for Welsh life science
Is your company in the picture? Welcome to Picture of Health Wales’ life science sector comprises over 200 companies and contributes significantly to the Welsh economy. Picture of Health seeks to build on that success allowing you to put your business “in the picture.”
search for a company or click on a particular area of the map
Whether you are looking to source collaborative partners, find out the latest news and developments or focus on international trade, Picture of Health will help keep you in touch with the life science sector . Register today and benefit from an unprecedented opportunity to network with like minded companies and organisations across Wales.
Get the picture?
Click on the icon to view a profile and connect
www.mediwales.com/pictureofhealth Delivered by
In collaboration with
Any questions? Contact MediWales
Tel: 029 2047 3456 pictureofhealth@mediwales.com
9
10
PP HH AA R MMAAC CE EUUT TI CI CAAL LSS PH A RR M ACEUTICALS
5% 5%
IN DD UU SSSTTTRRRI A N D U ALLLBBBI IO IO OTTTEEECCCHH H II N II A
19% 19%
5% 5%
C O M PA N I E S BY S E C TO R C O M PA N I E S BY S E C TO R
MM EEE DD IC M D ALLLTTTEEECCCHH HNN NOO OLLLOO OGGGYY YAA ANN NDD D DD DI IA IA AGGGNN NOO OSSSTTTIIICCCSSS II CCAA
4% 4%
MM EEE DD IC M D ALLLBBBI O OTTTEEECCCHH H II CCAA II O
W TT A A WEEELLLSSSH H LLLIIIFFFEEE SSSCCCIIIEEEN NCCCEEE S OR RS DA AT A W H N SS EEEC CC T TT O O R SS D D A
THE SUMMARY
the thesummary M PP LLO OY YM M EE N EE M N TT LL EE V VE L S
3% 3%
25% 71%
68% 68%
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Working with Welsh Government Welsh Government is supporting businesses to attend the following missions between 2014- 2015 Event Name
Dates
Location
Medica
11 -16 November 2014
Dusseldorf, Germany
Arab Health
24- 30 January 2015
Dubai, UAE
Tokyo (Japan) Trade Mission
25-31 October 2014
Tokyo, Japan
Mumbai (India) Trade Mission
26-31 October 2014
Mumbai, India
Big 5 Dubai
15-21 November 2014
Dubai, UAE
Mexico Trade Mission
25-30 January 2015
Mexico City/Guadalajara, Mexico
Seoul (South Korea) Trade Mission
7-13 February 2015
Seoul, South Korea
Doha (Qatar) & Muscat (Oman) Trade Mission
21-28 February 2015
Doha & Muscat, Qatar/Oman
Istanbul (Turkey) Trade Mission
1-6 March 2015
Istanbul, Turkey
Taipei (Taiwan) Trade Mission
14-21 March 2015
Taipei, Taiwan
Welsh Government- supporting international trade The Welsh Government Life Sciences international trade programme in 2012/13 was extremely successful providing support for over 100 delegates who represented over a fifth of all Welsh Life Sciences businesses. Medica 2013 was the largest ever Welsh Government delegation and 2014 looks set to match that.
UK Trade Support UK Trade and Investment also has a comprehensive programme of trade missions and trade shows. An extensive support for international trade activities is on offer for 2014/15 from Welsh Government, UKTI and ABHI. MediWales and other support organisations will circulate this information throughout the year. Different levels of subsidy or support are available depending on the event, the level of international trade experience which the company already has and the size and location of the company. For full details of both Welsh Government and UKTI supported missions please refer to our calendar at the rear of this directory.
Addressing areas of Unmet Clinical Need: A £4million Welsh Wound Innovation Centre of excellence in wound prevention and treatment has been established in Wales with the dual aim of delivering health and wealth benefits for people in Wales. The Welsh Wound Innovation Centre has a strong commercial focus on job creation and business as well as the delivery of a full range of clinical research and knowledge transfer services to the NHS and commercial customers.
THE SUMMARY
Selected Multi-Sector Trade Missions 2014/15:
Funding: The £100m Wales Life Sciences Investment Fund has made five investments to date. 1. In May 2013, Merthyr based Simbec Research Limited, one of the UK’s leading clinical research organisations, benefited from the first investment of the Fund. 2. In August 2013 Stem Cell Company ReNeuron became the second recipient of investment and as a result will be setting up its headquarters, research and development and manufacturing operations in Wales. 3. In March 2014, the Fund announced the third investment into AIM listed Verona Pharma a Pharmaceutical firm specialising in medicines to treat respiratory diseases, who will locate their headquarters to Wales. 4. The fourth investment announced in June 2014 and resulted in the acquisition of Orion Clinical Services, a late stage clinical development company, by Simbec Research to form Simbec-Orion Group Ltd. 5. In August 2014, the Fund invested in the Cardiff University spin-out Medaphor, a global provider of advanced ultrasound education and training for medical professionals.
11
thelife summary the science advisoryforum E M P LOY M E N T L E V E L S
Life science represents one of the most significant sectors of the Welsh economy 3% creating high value manufacturing jobs, exporting to global markets, and growing despite current financial conditions. Wales has significant strategic assets beneficial to this sector including excellent research activity, a devolved NHS, access to European markets, and an industry sector that already comprises a large number of global brands.
W E L S H L I F E S C I E N C E S E C TO R S DATA
4%
MediWales uses the forum’s discussions to facilitate communication between academics, businesses and clinicians and advise Welsh Government, as well as to shape its own activities such as international relations, a busy events programme, publications and membership support.
25% 71%
Quarterly meetings have resulted in these active projects:
MediWales-Pharma Special Interest Group, Clinical Trials Services Wales – Welsh Clinical Trials companies coming together to promote the Welsh pharmaceutical sector.
The forum actively improves the networking communications identifying and addressing future threats and opportunities for our members.
NHS Innovation Initiatives and Procurement – specialist breakout meetings between industry, the NHS and Welsh procurement services to develop strategies to solve the problems of innovation uptake and improve patient care.
MEDICAL TECHNOLOGY AND DIAGNOSTICS
THE ADVISORY FORUM
The Life Science Advisory Forum is a consortium of experts and senior personnel within the academic, business and clinical life science communities in Wales, this group advises MediWales on pressing issues within the sector.
Funding Opportunities – SBRI, Innovate UK, Welsh Government, Horizon 2020 for health and i4i, Finance Wales, Welsh Government’s Wales Life Sciences Investment Fund
68%
Greg Baily Paul Michael Andrew Thomas Chris Williams Andrew Davidson Paul Smith David Ford Catherine Ramsay
5%
For more information about any of these projects, please contact: debbie.laubach@mediwales.com
Technical Director DFSS Black Belt Managing Director Chief Operating Officer Managing Director Professor of Cancer Biology University Director Consultant
5%
C O M PA N I E S BY S E C TO R
12
MEDICAL BIOTECH
MediWales’ Directors
INDUSTRIAL BIOTECH
PHARMACEUTICALS
Picture of Health – a digital resource to showcase and connect different stakeholders in the Welsh sector
19%
Arjo Huntleigh GE Healthcare Rogue Resolutions Ig Innovations DTR Medical Cardiff University Swansea University Independent Consultant
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Tim Hewson Steven Bain Sue Bale Alison Payne Gareth Mayhead Patrick Hill Stuart West Rob Bigsby Gareth Kempson Fiona Withey Gareth Evans Ian Weeks Keith Harding Judith Hall Grace Carolan-Rees Peter Webber Kevin Schofield Jon Geen Gary Dowthwaite Shaun McBride Simon Jackson Melanie Goward Andrew Evans Mark Helmich David Powell Kier Lewis Huw Roderick Martin McHugh Jim Thurlow Michael Graz Andy Smallwood Derek Sheader Matthew West Sue Mills Nicholas Price-Jones John Roberts Peter Philips Ian Smith Michael Kruidenier Stephen Burt Greg May Rachel Curran Gerald Kelly Bjorn Rodde Marc Clement Brian Perkins Caroline Garrett Molly Price-Jones Beverly Luchmun
Patent Attorney R & D Director R & D Director Director Head of Technology Transfer Deputy Director Medical Physics Managing Director Development Director Chief Executive Officer Chief Executive Officer Business Development Manager Dean of Clinical Innovation Dean of Clinical Innovation Professor, Anaesthetics, Intensive Care and Pain Medicine, Director Chairman Global Market Manager - Medical R & D Director Product Manager Sales and Marketing Manager Group Managing Director Senior Investment Executive Partner Managing Director Lead Industry Manager R & D Director Business Development Manager Business and Technology Development Manager Chief Operating Officer Managing Director Head of Sourcing Open Innovation Manager Director Managing Director Business Development Manager Commercial & Manufacturing Director Director Chief Financial Officer European Business Development Manager Managing Director General Manager Commercial Manager General Manager Project and Risk Manager Executive Chairman Senior Development Manager Laboratory Services Senior Technical Associate Industry Lead
Abel & Imray Abertawe Bro Morgannwg UHB Aneurin Bevan Health Board ARP Associates Bangor University Betsi Cadwaladr University Health Board Biocatalysts Biomet Biomonde Biotec Services International Cardiff University, RACD Cardiff University, School of Medicine Cardiff University Cardiff University, Anaesthesia Innovation CEDAR - University Hospital Wales Cellpath Covaris Cwm Taf HB EKF Molecular Elite Electronic Systems Frontier Medical Products Finance Wales Geldards GX Group Health Research Wales Hywel Dda UHB Invacare Microsemi Microvisk Neem Biotech NHS Procurement Services Norgine Ortho Clinical Diagnostics (J&J) Packaging Coordinators Inc Pelican Feminine Healthcare Penn Pharma Princess of Wales Hospital, SMTL Q-chip Quay Pharma Rocialle Ruskinn Sharp Clinical Services Sony UK Tec Swansea University, College of Medicine Swansea University, Institute of Life Science Swansea University Synergy Health Tybio Welsh Government - NISCHR
THE ADVISORY FORUM
Advisory Forum
13
the theperformance summary
Government 1%
Outside Wales 5%
E M P LOY M E N T L E V E L S
MediWales Membership 4% 2014
Clinical 7%
Allied Sectors
3%12%
19%
25%
PERFORMANCE
Welsh Life Science Industry
71%
Up
56%
62% Up
5%
16%
5%
19%
Events: 18 Events. 838 attendees.
12% Membership: 25 new company members. C O M PA N I E S BY S E C TO R (38% increase in 2 years)
14
Representation and support: 134 companies supported, 207 events/meetings attended.
68%
Digital communications: 2,417 website visits per calendar month MEDICAL BIOTECH
Up
Up
INDUSTRIAL BIOTECH
PHARMACEUTICALS
18%
MEDICAL TECHNOLOGY AND DIAGNOSTICS
W E L S H L I F E S C I E N C E S E C TO R S DATA
Academic & NHS Research
Performance Increase 2013-14
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
MediWales events
Annual Awards Dinner: 320 attendees UK HealthTech Conference: 220 attendees
2013 Awards Dinner 320 attendees
Life Science Expert Advisory Group Meetings: 4 meetings: hosted by Cellpath, Geldards, Cardiff University, Sony UK
Online 2,417 Average web visits per month 791 followers 349 Linked-In members
Collaborative partners Association of British Healthcare Industries, BioPartner, Council of European BioRegions, Enterprise Europe Network, Knowledge Transfer Network, MedilinkUK, UK BioIndustry Association, One Nucleus, UK Science & Innovation Network, UK Trade and Investment
UK Lifescience Industry Magazine Circulation 2 x 2000 Digital Readership 39,500
PERFORMANCE
18 events: 838 attendees
Sponsors Abel & Imray, Elite, GX Group, Geldards
Business Support 207 events/meetings attended 134 companies directly supported 9 collaborations facilitated
Review and Annual Directory Circulation 1,090 Digital Readership 1,783
15
Life Science Industry Conference 4th December 2014, Cardiff, Wales
thesummary
One Conference - Two Essential Streams
• Pharmaceutical Development
The UK HealthTech Conference 2014 is to be held at the St David’s Hotel, Cardiff.
E M P LOY M E N T L E V E L S
The one day event will be a valuable day of briefings and networking for those within the pharmaceutical and medtech communities. Over 300 delegates are expected to come together in an integrated congress to understand critical strategic trends that will impact on the life science industry. The event will offer both the latest insights from key opinion leaders and networking with regulatory authorities and executives from the world’s leading industry, clinical and research organisations.
4%
W E L S H L I F E S C I E N C E S E C TO R S DATA
3%
Conference Rates:
Dinner and Networking:
Delegate Rate £250 (£175 for MediWales Members) Exhibitor Packages £850 (£600 for MediWales Members) Sponsorship Packages from £2,000
Following this event there will be a drinks reception and dinner.
25%
* All prices exclude VAT
71%
MEDICAL TECHNOLOGY AND DIAGNOSTICS
Partner Organisations
• Medical Technology
Keynote Speakers:
Professor Sue Hill, Chief Scientific Officer for England, NHS
Plenary Sessions:
• Regulatory Update from the Medicines and Healthcare Products Regulatory Agency (MHRA )
John Wilkinson OBE, MHRA
Gary Stapleton, Business Director, 3M, West Europe
• Open Innovation and Big Data in Healthcare Research PHARMACEUTICALS
• Regenerative Medicine and Wound Healing • Welcome Trust funding for Innovations
Pharma Development Seminar Stream • • • •
19%
MedTech Seminar Stream
The Impact of Regulatory Changes - Falsified Medicine Directive Security of the Supply Chain New EU Clinical Trials Regulation Funding for R & D and Clinical Trials
5%
MEDICAL BIOTECH
INDUSTRIAL BIOTECH
• Personalised Medicine and Companion Diagnostics
68%
5%
• The Impact of Regulatory Changes - Medical Device Directive and In Vitro Diagnostics • UK Procurement Landscape and Innovation Initiatives • Funding for R & D and New Product Development • Engaging with the NHS - Clinical Unmet Needs
For exhibition and sponsorship opportunities or for more information, please contact lucinda.dargavel@mediwales.com, +44 (0) 2920 473456 Visit www.ukhealthtech.com for latest conference updates. Conference delivered by Companion Events:
16
C O M PA N I E S BY S E C TO R Media:
Partnering:
lifesciences@geldards.com
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
0844 736 0006
FAST, COMMERCIAL, PRACTICAL GREAT INDUSTRY KNOWLEDGE WITH
Legal 500 2012 Geldards is one of the country’s leading regional law firms. Our clients, in both the private and public sectors, trust us to give them high quality legal advice that is practical, commerciallyminded and value for money.
Our dedicated healthcare and life sciences team has a strong track record in dealing with medical technology, know-how licensing, research & development collaborations, commercial contracts and commercial & intellectual property disputes.
United Kingdom
Production and distribution is supported by partners including: ● Medilink East Midlands ● Medilink North West
INDUSTRY
Well informed. Well read.
● ABHI ● HealthTech and Medicines KTN
News, developments and analysis from the magazine at the heart of the UK Lifescience Industry. Published in partnership with Medilink UK and its partner organisations who are in daily contact with leading innovators, UK Lifescience Industry provides:
● iNets South West Biomedical ● Scottish Enterprise
● Cutting edge analysis
● SEHTA
● Leading scientific opinion ● A perfect platform for advertising
● Medilink South West ● Medilink West Midlands ● Medilink Yorkshire & Humber ● MediWales
Distributed to 38,000 named individuals with an estimated total readership of 100,000
● Print and digital formats
PUBLISHED IN PARTNERSHIP WITH MEDILINK UK
Make sure you book your place Contact: lucinda@uklifescienceindustry.com
or call +44(0) 29 2047 3456
17
thesummary
3 Assembly Square Britannia Quay Cardiff CF10 4PL t +44 (0) 29 2089 4200 f +44 (0) 29 2089 4201
E M P L O Y M E N Te Lai@patentable.co.uk EVELS w www.patentable.co.uk
W E L S H L I F E S C I E N C E S E C TO R S DATA
3% Quality advice on your doorstep 4% London isn’t the only place for quality patent and trade mark advice. Discerning businesses already know that there’s knowledgeable advice and extensive experience in Cardiff. Our medical technology team has wide-ranging expertise in protecting innovations and branding in the life science sector. Biotechnology, genetics, medical devices, diagnostics, medical imaging, medical electronics and pharmaceuticals – we’ve got it all covered.
25%
71%
C O M PA N I E S BY S E C TO R
18
19%
MEDICAL TECHNOLOGY AND DIAGNOSTICS
5%
MEDICAL BIOTECH
5%
INDUSTRIAL BIOTECH
PHARMACEUTICALS
Abel & Imray combines premium standard expertise with a friendly, helpful approach. It’s a service you’d go a long way to find – but it’s all here for you in Cardiff Bay in the same building as Wales’ new Life Sciences Hub.
68%
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
thecontacts UK/Regional Partners and Networks:
NHS and Research Organisations:
Medilink UK +44 (0)121 452 5630 www.medilinkuk.com
National Institute for Social Care and Health Research (NISCHR) - Abbey Owens, Administrator, contact-AHSC@wales.nhs.uk, +44 (0)29 2019 6816 www.nischr-ahsc.org.uk
Association of British Healthcare Industries Ellie Charsley, Communications, ellie.charsley@abhi.org.uk, +44 (0)20 7960 4360 www.abhi.org.uk One Nucleus Tony Jones, Director of Business Develooment tony@onenucleus.com +44 (0)1223 896450 www.onenucleus.com BIA Karen Chandler-Smith, Director of Business Development, KChandler-Smith@bioindustry.org +44 (0)20 7630 2180 www.bioindustry.org BioPartner Lin Bateson, Executive Director, Operations lin@biopartner.co.uk +44 (0)20 7193 7815 www.biopartner.co.uk Scottish Enterprise Ulrike Knies-Bamforth ulrike.knies-bamforth@scotent.co.uk +44 (0)131 3136011 www.scottish-enterprise.com
Health Research Wales Cait Myers-Officer, contact@healthresearchwales.com, +44 (0)29 2023 0457 www.healthresearchwales.com LIFE, The Life Science Exchange Brian Perkins, Business Development Manager b.l.perkins@swansea.ac.uk, +44 (0)1792 602 865 www.lifesciexchange.com Medicines and Healthcare products Regulatory Agency (MHRA) www.mhra.gov.uk National Institute for Health Research (NIHR) www.nihr.ac.uk National Institute for Health and Care Excellence (NICE) Notifications & External Engagement Manager Medical Technologies Evaluation Programme, National Institute for Health and Care Excellence, Lee Dobson lee.dobson@nice.org.uk +44 (0)161 2193862 www.nice.org.uk/mt
CO N TAC T S
Knowledge Transfer Network - Health Community Narpal Sihra, Knowledge Transfer Manager, narpal.sihra@ktn-uk.org +44 (0)1223 842692 connect.innovateuk.org/web/healthktn/
Funding: Invention for Innovation (i4i) programme www.ccf.nihr.ac.uk/i4i Wellcome Trust www.wellcome.ac.uk/funding innovateuk www.innovateuk.org
International Partners: Welsh Government - Life Sciences Team, lifesciences@wales.gsi.gov.uk, +44 (0)3000 603000 UK Trade & Investment (UKTI) John Lownds, UKTI Life Sciences, john.lownds@ukti.gsi.gov.uk, +44 (0)20 7215 8086
Welsh Government www.wales.gov.uk/funding National Institute for Social Care and Health Research www.wales.nhs.uk/sites3/home.cfm?orgid=952 Department of Health/National Institute for Health Research www.ccf.nihr.ac.uk Horizon 2020 www.ec.europa.eu/research/horizon2020
CEBR - Council of European BioRegions Claire Skentelbery, Network Manager info@cebr.net +32 (0)493 109 1810
Business Support: Welsh Government - Life Sciences Team, lifesciences@wales.gsi.gov.uk, +44(0)3000 603000
19
Members’ Directory 2014 Medical Technology & Diagnostics
Charities
Academic
Pharmaceuticals & Clinical Trials Services
Professional Services & Suppliers
KEY
NHS, Contract Research & Testing
Medical Technology & Diagnostics 3M
The Science Park Technology Drive Bridgend CF31 3NA +44 (0)7785 385940 www.solutions.3m.co.uk/wps/ portal/3M/en_GB/HealthCare/ Home/ csedgemore@mmm.com
3M Food Safety Bridgend is part of 3M Healthcare which offers innovative products and solutions for skin & wound care, infection prevention, oral care, health information systems, drug delivery and food safety. Bridgend is the development and manufacturing site for rapid hygiene testing and microbial screening products for use by dairy, food and beverage manufacturers. The products are also used in other applications including hospital hygiene, monitoring biocide treatment of industrial waters and in biodetection systems for defence agencies. The Bridgend manufactured products are part of a wider portfolio from 3M Food Safety which includes PetrifilmTM sample ready plates for enumeration of microorganisms, TecraTM pathogen test kits and a range of sample handling and media products. 3M Healthcare is part of the 3M Company, a diversified technology company with a turnover of $23.1billion and widely recognised as one of the world’s most innovative organisations.
Acuitas Medical Unit 8, Technium One Kings Road Swansea Waterfront Swansea SA1 8PH +44 (0)1792 485705 www.acuitasmedical.com jheinrich@acuitasmedical.com
Swansea-based Acuitas Medical is currently in the final stages of product development of a proprietary Magnetic Resonance Imaging (MRI) based technique – Fine Structural Analysis (fineSA™). Extensive human and animal studies have demonstrated that fineSA will identify non-invasively early changes in anatomical structures which may be associated with the early stages of disease. fineSA is expected to provide an entirely new method in diagnostic imaging, providing information on anatomical scales that cannot be visualized with existing in-vivo methods. fineSA data can be acquired in as little as 15 seconds and can be readily installed on any MRI imaging system, without modifications or additional hardware.
Applied Enzyme Technology The Gwent Group Monmouth House Mamhilad Park Pontypool NP4 0HZ +44 (0)1495 750505 www.gwent.org/aet guido@gwent.org
20
Applied Enzyme Technology Ltd (AET) was established in 1994 with core expertise and patents in protein stabilisation, which has resulted in the successful stabilisation of many enzymes and antibodies in a number of medical biosensor devices. AET in partnership with Gwent Electronic Materials Ltd is able to develop and manufacture biosensors for diagnostic, healthcare and point-of-care applications. Sensors being developed for clients include glucose, cholesterol, creatine, ammonia, pyruvate, organophosphates, alcohol and cardiac markers. The Gwent Group of companies is capable of manufacturing up to 500,000 sensors per annum.
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Asalus Medical Instruments Suite 18, Cardiff Medicentre, Heath Park Cardiff CF14 4UJ +44 (0)29 2068 2106 www.asalus.co.uk info@asalus.co.uk
Asalus was established in 2009 to commercialise the inventions arising from the Wales Institute of Minimal Access Technology (WIMAT) in Cardiff. WIMAT is a leading UK centre for training of laparoscopic and other surgical disciplines. Having access to both highly experienced key opinion leaders and new trainees places WIMAT in a privileged position to receive feedback on modern surgical techniques. Asalus works with WIMAT and its network to identify issues with these procedures and potential solutions for them. Asalus then rapidly prototypes medical devices and tests whether or not the devices are capable of addressing these issues. Prototypes that successfully pass this decision point then enter full development. The company has strong relationships with a broad network of product development partners that allow it to take forward a wide range of mechanical and electrical product concepts. Through its network of contacts within global medical device companies and distributors, Asalus is ideally placed to rapidly partner products with leading players in the sector to maximise the adoption of each device it develops. Its first product, Ultravision, is a revolutionary new way of handling surgical smoke that is created during laparoscopic surgery. The product was awarded the CE mark in 2014 and subsequently received the Royal College of Surgeons Cutlers Surgical Prize.
B & V Group Lamport Drive Heartlands Business Park Daventry NN11 8YH +44 (0)8443 727344 www.bvwater.co.uk enquiries@bvwater.co.uk
Established in 1977 and headquartered in Daventry, UK the B & V Group has a high degree of technical expertise and a real focus on research and development providing technology, equipment, products and services to the life science and water treatment sectors. Our aim is to always provide the best available technology and support to our customers and to work closely with regulatory bodies and Government organisations. The seven divisions within the B & V Group are Life Sciences, Water Treatment, Training Academy, Oil and Gas, Effluent Services, Own Label Products and Engineering. B & V Life Sciences, develops and manufactures technology for the health care sector, from water disinfection to new generation human and animal wound care products via a new ISO 13485/ISO 9001/ISO 14001 certified production plant. The human wound care products have been developed in partnership with a major UK based pharmaceutical company and the animal health products are packaged in North Wales. B & V Training Academy uniquely provides Ofqual accredited courses on legionella control and is working with the NHS and Facilities Management Companies to develop specific courses with formal qualifications on areas such as compliance to HTM 04 -01. B & V Water Treatment has developed the best available technology for water treatment within the health care environment and regulatory factors and increased awareness from hospitals is providing strong demand for such technology. New generation products such as Abulox provide exceptionally high levels of microbial control thus reducing nosocomial infections.
Biocatalysts Cefn Coed Parc Nantgarw Cardiff CF15 7QQ +44 (0)1443 843712 www.biocatalysts.com sales@biocats.com
Biocatalysts is a specialty enzyme manufacturer that focuses on enzyme discovery, development and manufacture for a range of industries including API manufacture, diagnostic enzymes and fine chemicals. We differentiate ourselves by being able to offer anything from small scale laboratory samples through to large scale, long term manufacturing of stabilised product. These products are available in a variety of forms, all suitable for global shipment with the appropriate paperwork for regulatory compliance in its target market. The company has recently invested over £1 million in new equipment which has added another level of flexibility and scale to our current offering. Further expansion plans are now underway.
BioMonde Units 2-4 Dunraven Business Park Coychurch Road Bridgend CF31 3BG +44 (0)845 230 1810 www.biomonde.com enquiries@biomonde.com
BioMonde have two manufacturing facilities; one is located along with its head office at Bridgend, South Wales and a second in Hamburg, Germany. The company produces larval debridement therapy products for the treatment of sloughy and necrotic wounds. All products are produced in accordance with current European ‘Good Manufacturing Practice’ (GMP) requirements in state-of-the-art aseptic facilities. Free Range larvae and BioBag® Dressings are BioMonde’s core products. BioBag® Dressings contain larvae that are enclosed in net pouches with spacing to protect the larvae. The BioBag® products can be left on a wound for up to four days. The Free Range larvae are applied directly to the wound so they can seek out areas of slough or necrotic tissue. They are contained on the wound via a sterile retention net system, which is a CE-marked medical device also produced by BioMonde.
21
Calon Cardio-Technology Institute of Life Science Swansea University Swansea SA2 8PP +44 (0)1792 602811 www.caloncardio.com info@caloncardio.com
Calon Cardio-Technology Ltd (Calon) is developing a new generation of implantable Left Ventricular Assist Device (LVAD) for the treatment of heart failure. Current pumps have clinically proven that LVADs are a safe and effective therapy. However, these devices have so far failed to exploit their huge market potential for two reasons: current products are too large (requiring highly invasive surgery) and they are expensive at circ $115,000 per system. Calon’s technology addresses both problems and promises to realise the vision of LVADs becoming the routine method of treatment for heart failure. Calon have assembled a team of world class suppliers and collaborators to take their vision to market, such as Texas A&M, The John Radcliff Hospital Oxford, Swansea University, The Technology Strategy Board and the Welsh Government.
CellPath 80 Mochdre Enterprise Park Newtown Powys SY16 4LE +44 (0)1686 611333 www.cellpath.co.uk sales@cellpath.co.uk
CellPath Ltd specialise in the manufacture and world-wide supply of products, consumables and services for the histopathology and cytology markets. The Human Tissue Authority licensed archive management solution, CellNass, offers a complete answer to healthcare providers by administering pathological material in a purpose built facility, thus releasing valuable time and space for other uses. CellPath has a state of the art injection moulding capability and manufactures many of the plastic products that are used in the modern histology and cytology laboratories. The recent acquisition of further premises in Newtown has resulted in an expansion process to manufacture more products in-house, including chemicals such as stains and fixatives. The ability to sell directly from manufacture to the end user enables cost-saving without compromise on quality and service. A recent development for 2013 was the addition of the CellTec range of small laboratory instruments. CellPath has a continuous improvement process built around a strong desire to maintain a high level of quality, with ISO 9001:2008 and ISO 13485:2003 accreditation. Lean techniques are implemented throughout our operations including ‘5S’ philosophy. A recent audit by the HTA declared that the CellNass service is of the highest possible standard.
Chromogenex Technologies Units 1&2 Heol Rhosyn Dafen Park Llanelli SA14 8QG +44 (0)1554 755444 www.chromogenex.com sellis@chromogenex.com
Chromogenex Technologies design, manufacture, and service lasers and intense light systems for the health, cosmetic and beauty markets. Our products are: iLipo: a body shaping, fat reduction device without the need for pain, needles or downtime Phaser EPL: intense pulse light (ipl) for hair removal, skin rejuvenation and pigmentation Regenlite Transform: a pulse dye laser for fast, effective treatment for inflammatory skin conditions Plus Fusion SLR: for non-invasive skin rejuvenation, including systems for tattoo removal, pigmentation, vascular lesions, psoriasis, cellulite and vitiligo iLipoXcell: the most advanced non-surgical fat reduction and body shaping system The company has established direct sales operations in the UK, with a worldwide distribution network.
Coveris Advanced Coatings Ash Road North, Wrexham Industrial Estate Wrexham LL13 9UF +44 (0)1978 660241 www.coverisadvancedcoatings.com enquiries@coveris.com
Coveris Advanced Coatings are global leaders in the development, manufacture and distribution of precision coated papers, films and speciality substrates for imaging, electronics, medical and optical technologies. We also offer unique speciality films and Coating Services including contract coating, toll coating and converting. Coveris Advanced Coatings’ inspire® brand reflects thirty years of development and manufacturing expertise in the medical marketplace. The inspire portfolio offers a variety of medical components for wound care, ostomy and medical devices, from ultra-thin polyurethane films and polyurethane foams to innovative medical grade adhesives and conductive films. The materials are produced in ISO 9001-2008 facilities to exacting standards in a clean room environment and are tested to ensure compliance with the appropriate regulatory standards. With manufacturing and converting in the UK and the USA, and conversion/ distribution from China, Coveris Advanced Coatings has a global capability to meet customer needs. The inspire® range of polyurethane materials benefit from a surface with a very low coefficient of friction, good breathability (MVTR) and provides a barrier against bacteria – all essential properties for advanced wound care products. The conductive materials, with z-directional conductivity are used extensively in ECG, TENS and bio-sensors. Whether it is a standard product or a specific design with tailored properties, the team at Coveris Advanced Coatings is eager to discuss your opportunities.
22
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
DTR Medical
17 Clarion Court Enterprise Park Swansea SA6 8RF +44 (0)1792 797910 www.dtrmedical.com info@dtrmedical.com Twitter: @dtrmedical
DTR Medical is an innovative medical device and cleanroom contract manufacturer, with the ability to design, CE mark, manufacture and sterilise a wide range of healthcare products. DTR Medical’s custom-built facilities include a versatile ISO class 7 cleanroom complex, operated by a highly trained team. Experienced in the manufacture and packing of many medical devices used in ENT, Gynaecology, Vascular Neurology, Orthopaedic and general surgery. DTR Medical sells and markets its own brand of sterile single-use surgical instruments, developing new and innovative products including the new Rotating Cervical Biopsy Punch, winner of the ‘MediWales Innovation Award’ for its overall design and use of advanced manufacturing techniques. The company already contract manufactures a wide range of custom-built products for the pharmaceutical, biotechnology and diagnostic industries. Fully equipped to handle flow wrapping, shrink wrapping and vacuum packing. The facility also has specialist expertise in handling liquid filling of medical devices and related products
EKF Diagnostics Avon House 19 Stanwell Road Penarth Cardiff CF64 2EZ +44 (0)29 2071 0570 www.ekfdiagnostics.com info@ekfdiagnostics.com
EKF Diagnostic Holdings plc specialises in the development, production and distribution of near patient analysers, clinical chemistry and DNA enrichment kits for use in the detection and management of diabetes, anemia, lactate and kidney related diseases. The EKF range of analysers is unique in their ease of use, accuracy and portability which is why we are a trusted brand in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c. EKF Diagnostics products’ reputation for quality, accuracy and ease of use stems from our beginnings as a technology business founded in Barleben in Germany in 1990. In the following years we have invested in developing a portfolio of analysers and consumables for the near patient care sector that deliver laboratory accuracy and reliability without the high costs and maintenance associated with lab devices.
EKF Molecular Diagnostics Ltd Avon House EKF Molecular Diagnostics is introducing new technologies and products with the potential to change current DNA 19 Stanwell Road extraction and detection practices. PointMan DNA Extraction kits are now available for KRAS, BRAF and EGFR T790M SNP Penarth enrichment. Our pipeline includes a multiple SNP/deletion EGFR kit and kits to enrich for JAK2, PI3K and KRAS codon 61. Cardiff CF64 2EZ +44 (0)29 2071 0570 www.ekfmolecular.com garydowthwaite@ekfmolecular.com
E2L Products 19 White Swan Court Priory Street Monmouth NP25 3NY +44 (0)1600 714856 www.e2l.uk.com info@e2l.uk.com
Engineering product designers with electronic, mechanical and industrial design skills, providing consultancy design services, joint venture development and proprietary products. Focussed on design simplicity, alternative thinking and functional necessity. ISO 9001:2008 certified. Track record of product development collaboration with NHS and individuals. R&D resource for new products/inventions requiring electronic and mechanical engineering inputs, product rescue and ongoing development. Expertise with portable systems, battery operated, low power systems, wireless communications. Preferred route to market is collaborative idea, licence agreement with originator, R&D then distribution by E2L. Essentially you retain ownership, we convert your idea into a product and take it to market. Products are all sold through third party agents or joint venture partners. Actively involved in various health areas including AAC, anaesthesia, urodynamics, dementia, simulation, eldercare and orthopaedics.
23
Frontier Medical Group Newbridge Road Industrial Estate Blackwood NP12 2YN +44 (0)1495 235800 www.frontier-group.co.uk info@frontier-group.co.uk
Frontier Medical manufacture and market a range of medical products in three broad business streams: Sharpsafe is Europe’s leading brand of plastic sharps disposal containers. Repose is a range of inflatable polyurethane pressure redistribution devices for the prevention and treatment of pressure ulcers, manufactured under license from the NHS. Exchange is the brand under which products are made available to organisations for harm reduction purposes amongst the intravenous drug-using community. Frontier is based at two factories in Blackwood with facilities for plastic injection moulding and welding. The core market in the UK is the NHS although approximately 50% of production is exported, mostly to the EC.
GE Healthcare GE Healthcare is an Anchor Company in Wales located on a 30-acre Cardiff site, known as The Maynard Centre which is involved in delivering breakthroughs in research & development and in biopharmaceutical manufacturing. The Maynard Centre makes approximately 6,000 products every year with a global sales value of around $180m. These consumable products are used to detect, label, purify, amplify & analyse DNA and proteins. Other products include paper and glass fibre used in basic filtration and clean room manufactured plastic encased membranes used in sample preparation, medical diagnostics and research applications. Cardiff Laboratories Forest Farm Rd Whitchurch Cardiff CF14 7YT +44 (0)29 2052 6421 www.gehealthcare.com/uken paul.michael@ge.com
The Maynard Centre is also the global headquarters of GE Healthcare’s Cell BioProcessing business, home to a world-class stem cell laboratory, considered by GE Healthcare to be a Centre of Excellence. The site has helped to develop cellular reagents and assays for high-content screening on automated imaging platforms. This encompasses stem cell extraction and expansion tools including cardiomyocytes used in drug discovery. The company’s 10,000 plus customers include the pharmaceutical and biotechnology industry, academia, organisations involved in human identification and diagnostics work, and industrial and consumer companies like Coca Cola. The Maynard Centre has a highly skilled global workforce representing one of the most diverse in the area.
Glyconics Ltd c/o Broomfield Alexander Charter Court Phoenix Way Enterprise Park Swansea SA7 9FS +44 (0)776 969 8686 www.glyconics.com berwyn@glyconics.com
Glyconics Ltd is a start-up/spin-out from Swansea University. We have developed a technology for accurate diagnosis of COPD at both laboratory level and at point-of-care. Glyconics will be manufacturing and selling hand-held devices into the majority of global markets since COPD is a significant clinical problem.
Haemair Unit 5, Room 403 ILS Phase 2 Swansea University Singleton Park Swansea SA2 8PP +44 (0)1792 602466 www.haemair.com sbrown@haemair.com
Established in 2005 and based in Swansea, Haemair are developing the next generation Extracorporeal Membrane Oxygenation (ECMO) device. The initial focus is on post-operative support following cardio pulmonary surgery where it can both improve recovery rates and reduce hospital stays. Respiratory problems cost the NHS over £2,500 million/annum. The much larger cost to society ranges from lost time at work to long-term support in homes and care homes. In the longer term, ECMO promises to support patients with both acute and chronic respiratory problems. Competitive devices are associated with an increased risk of blood clot formation requiring a level of anticoagulation that significantly increases the risk of haemorrhage. This risk currently limits ECMO use to a small number of high-cost specialist centres. Haemair have demonstrated a device with the potential to reduce the risk of blood clots and hence greatly increase access to ECMO. Haemair has raised over £2million in private equity investment and has also benefitted from grants from the Welsh Government and from the NHS.
24
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Hospital Innovations Concept House Talbot Green Business Park Pontyclun, CF72 9FG +44 (0)1443 719555 www.hospitalinnovations.com/ info@hospitalinnovations.co.uk
Hospital Innovations Limited was founded in January 2008, our portfolio includes bone graft substitutes, sports medicine allograft as well as specialist grafts such as meniscus and osteochondral allograft. Two years ago we added a surgical division supplying products into the surgical disciplines of Urology, General surgery and Gynaecology. This year we have just launched two divisions to bring products and technologies to the fields of dental and Wound Healing.
Huntleigh
Diagnostic Products Division Unit 35 Portmanmoor Road East Moors Cardiff CF24 5HN +44 (0)29 2048 5885 www.huntleigh-diagnostics.com sales@huntleigh-diagnostics.co.uk
Huntleigh, a member of the Getinge group of companies, is a leading global provider of innovative and high quality medical equipment for healthcare professionals. The Diagnostic Products Division markets its products globally under the ‘Sonicaid’, ‘Dopplex’, and ‘Smartsigns’ brands, covering health care requirements in Obstetric care, Vascular Assessment, and Patient Monitoring. The ISO13485 accredited site at Cardiff designs, manufactures and distributes a broad portfolio of electronic medical products thanks to its extensive R&D capability. These innovative products include market leading pocket Dopplers used for vascular assessment and fetal heart rate monitoring. The factory also manufactures a comprehensive range of fetal monitors for antenatal, labour and delivery applications, together with a range of patient, bedside and vital signs monitors. To enhance the product ranges and provide a seamless electronic data management solution, a range of clinical information systems have been developed, and are available with full technical and clinical support services.
Ig Innovations
Gernos Maesllyn Llandysul SA44 5LP +44 (0)1239 858972 www.ig-innovations.co.uk chris.williams@ig-innovations.co.uk
Committed to improving patient care and quality of life, Ig Innovations Ltd and its parent company Mologic Ltd are dedicated to breaking new ground in diagnostic research. From innovation to manufacture, our portfolio of expertise includes assay and reagent development, antibodies with unparalled performance to challenging targets, diagnostic platforms and clinical evaluation studies. With a successful track record we are molecular minded in stepping outside the bounds of what cannot be done and in doing so always generating transformable IP. Ig Innovations Ltd itself offers bespoke antibody production and supply to the research, diagnostic, biotech and pharmaceutical sectors: from antigen design, peptide synthesis, conjugation, through to antibody purification, conjugation and assay development. We can deliver small volumes to the research customer through to large pools to satisfy assay lifetime requirements of in-vitro diagnostic customers. Ig Innovations offers a large catalogue of antibodies from high volume stocks, available in any format that the customer requires. Employing our wealth of experience we can work with customers to advise and consult on specific antibody requirements and assay development, in particular POC. Ig Innovations Ltd is an Alere Company. Experienced and capable partner for grant applications for immunoassay diagnostic projects.
Invacare (UK) Pencoed Technology Park Pencoed Bridgend CF35 5AQ +44 (0)1656 776222 www.invacare.co.uk uk@invacare.com
Invacare’s UK operations were founded in 1856 and the company now employs 255 people. Based in South Wales, the company is ideally placed to provide the UK healthcare market with a range of products and services that meet the demands of both the public and private sectors. Over the years, Invacare UK has selected and merged with a number of UK manufacturers to offer a selection of wheelchairs, scooters, respiratory, community beds, bathing aids, lifting equipment, support surfaces and seating and positioning products. Invacare’s commitment to product design and quality has resulted in a comprehensive product portfolio.
MedaPhor Suite 4 and 16 Cardiff Medicentre Heath Park Cardiff CF14 4UJ +44 (0)29 2075 6534 www.medaphor.com stuart.gall@medaphor.com
MedaPhor is the UK’s leading ultrasound education and training company, producing innovative training products for postgraduate medical professionals. MedaPhor’s range of products and services includes the new award winning ScanTrainer Transvaginal Simulator, a virtual ‘real-feel’ ultrasound training simulator, which provides curriculum-based training, independent of a clinical setting. The company also sells a range of e-learning ultrasound modules and organises regular 3-day ‘hands-on’ ultrasound courses in Cardiff for obstetrics and gynaecology. MedaPhor’s products and services are suitable for postgraduate students, gynaecologists, obstetricians, radiographers, midwives and nurses to develop critical knowledge and skills as part of their training. They are also suitable for practitioners for fulfilling their continued professional development (CPD) and for trainers, as an indispensable teaching resource for the classroom and lecture theatre. MedaPhor is committed to creating high-quality ultrasound training systems for worldwide medical healthcare.
25
Microsemi Phase 2, Castlegate Business Park Portskewett Caldicot Monmouthshire NP26 5YW +44 (0)1291 435342 www.microsemi.com martin.mchugh@microsemi.com
Microsemi’s Advanced Packaging Division delivers competitive advantage for its customers through miniaturising electronic circuits, enabling wireless connectivity and developing novel energy sources for medical devices. With a track record of success in designing and developing miniaturised electronic modules, Microsemi’s Advanced Packaging Division is at the heart of mission-critical projects in such applications as pacemakers, neurostimulators, sensors, hearing aids and patient monitoring. Technology development is underpinned through TSB and FP7 collaborations with leading research organisations and companies where Microsemi plays a leading role in management and exploitation. Current projects include energy harvesting, In/on body wireless communications and embedded components to drive the next generation of 3D miniaturisation.
Microvisk Technologies Innovation House Unit 4 Ffordd Richard Davies St Asaph Business Park Debighshire LL17 0LJ +44 (0)8459 569900 www.microvisk.com enquiries@microvisk.com
Microvisk is a medical device company based in St Asaph, North Wales. We have developed a proprietary technology which creates moving parts on the surface of silicon chips. Using this technology we will shortly launch an instrument which measures blood thinning for people who take Warfarin, enabling the Warfarin dose to be optimised. In addition to at the surgery and hospital, the instrument can be used by the patient at home, removing the need to travel to the surgery on a regular basis. The technology has the potential for many more medical applications.
Momentum Bioscience Ltd Unit 19 Willowbrook Technology Park Llandogo Road St Mellons Cardiff CF3 0EF +44 (0)7919 538136 www.momentumbio.co.uk bmullen@momentumbio.co.uk
Rapid detection of infection in the hospital microbiology laboratory. First product due for launch Q1 2015 will be a negative exclusion assay to confirm absence of infection in blood cultures 17hr after specimen receipt by the lab.
Ortho Clinical Diagnostics
Felindre Meadows Pencoed, Bridgend CF35 5PZ +44 (0)1656 778000 www.orthoclinical.com/en-gb/Pages/ Home.aspx ocduk@ocdgb.jnj.com
Ortho Clinical Diagnostics has an established track record of serving the transfusion medicine community and clinical laboratories around the world. We are a leading provider of total solutions for screening, diagnosing, monitoring and confirming diseases early before they put lives at risk. Our single focus is to help hospitals, laboratories and blood centres worldwide deliver results that help patients experience a better quality of life. The facility at Pencoed, near Bridgend supplies Immunoassay and Immunohaematology products to markets around the world.
Pelican Feminine Healthcare Ltd Greypoint Cardiff Business Park Cardiff CF14 5WF +44 (0)29 2074 7400 www.pelicanfh.co.uk nicholas.pricejones@pelicanfh.co.uk
Pelican Feminine Healthcare Ltd is a UK manufacturer of single-use medical instruments. Pelican manufactures a range of single-use instruments, specialising in Gynaecology products, which include the market leading PELIspec. With state of the art manufacturing facilities and active research and development, the company has been instrumental in bringing many innovative products to the healthcare market. This, together with a positive input from specialist clinicians and other professional customers, ensures that Pelican Feminine Healthcare remains at the forefront of providing clinically and cost effective products. Pelican Feminine Healthcare is passionate about delivering high quality medical products and world class levels of customer service.
26
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Promove UK 72 Geryllan Penrhyncoch Aberystwyth SY23 33HQ +44 (0)1970 820893 www.promove.uk.com enquiries@promove.uk.com
Promove UK design and manufacture manual handling slings to move incapacitated people when a hoist is not available. Designed by a disabled person the design was a winner in Medical Devices at Geneva International Inventions Salon, 2008. Used by ambulance services, schools and colleges, disabled individuals, airports.
Pulse Medical Technologies Swansea University Singleton Park Swansea SA2 8PP +44 (0)1792 606670 www.pulsemedtech.com/ www.amethystwoundproject.com francis.cooper@pulsemedtech.com
Pulse Medical Technologies designs and manufactures medical devices for pain relief and wound healing. Pulse Medical Technologies was incorporated to design and develop pain relief and wound relief products using the therapeutic and healing properties of Pulse Electro-magnetic Field Therapy (PEMF), which has been cleared by the major national international Medical Authorities to treat medical conditions such as non-union bone fractures, wound healing and pain relief. The company is based in the prestigious Institute of Life Sciences in Swansea University and has access to world class research and development facilities and personnel who are currently working on its projects. The company’s main activity currently centres on the FP7 grant funded project called AMETHYST, which stands for: Ambulatory Magneto-Enhancement of Transdermal High Yield Silver Therapy Coming from a background in producing medical devices for pain relief using PEMF and through the extensive research the company undertook into PEMF for wound healing, it became evident that there was a large unmet need to develop an innovative solution to increase the speed of healing for chronic leg ulcers. The project entails passing an electromagnetic wave through silver to increase the efficiency of wound healing. Results to date have been extremely encouraging and the project is on target to be very successful. The company has been granted a European patent to cover the concept and is in the process of securing worldwide protection.
Rocialle
Cwm Cynon Business Park Mountain Ash
Rhondda Cynon Taf, UK CF45 4ER +44(0)1443 471347 www.rocialle.com/ stephen.burt@rocialle.com
For over 30 years, Rocialle has supplied healthcare providers with sterile and non-sterile consumable items, vital to patient care. During this time, Rocialle has become widely regarded by both clinical and commercial specialists as a reliable partner, sharing the objectives of improved patient experience, cost reduction and the focus of resources on patient care. With its wide range of single-use surgical instruments and medical packs, Rocialle is helping healthcare providers control infection and drive down the cost of high quality medical products. Production takes place in one of the largest medical clean rooms in Europe, which, together with an on-site e-beam sterilisation plant, enables Rocialle to be highly responsive and flexible in meeting customers’ requirements. Rocialle is part of Berendsen plc, a FTSE 250 company.
Rogue Resolutions Rogue Resolutions believe in the importance of developing and maintaining strong links between academia and industry, in order to improve and streamline knowledge transfer between those working in research and those working in industry. Our portfolio of services and products includes a range of “best-in-class” devices in the fields of: Sophia House 28 Cathedral Road Cardiff CF11 9LJ +44 (0)29 2066 0198 www.rogue-resolutions.com info@rogue-resolutions.com Twitter: @rogue_resol
Neuronavigation Neuroimaging (including EEG, fNIRS, analysis software and fMRI compatible devices) Neuromodulation (including TMS, rTMS, cTMS, tDCS, tACS and tRNS) Neurosensory Systems (including Eye-tracking, Response devices and Stimulus control software) In collaboration with our technical partners Rogue Research Inc. and neuroConn GmbH and in conjunction with our research customers, we are able to remain at the cutting edge of research and product development both in techniques and technologies. We believe that the key to development within our sector is through collaboration and we will strive to drive innovation through a collaborative and sharing approach.
27
Spectrum Technologies Western Avenue Bridgend CF31 3RT +44 (0)1656 655437 www.spectrumtech.com sales@spectrumtech.com
Spectrum Technologies is a world leader in the design and manufacture of high-tech laser processing solutions for advanced manufacturing. Product offerings for the medical industry include laser part marking systems for marking UDI and other ID codes onto polymer materials and metals; laser stripping systems for the non-damaging removal of insulation from fine wire, cable assemblies and magnet wire coils used in medical devices; and optical mark reading and verification QA systems.
Springdew Limited Units 9-12 Woodlands Business Park Ystradgynlais Nr Swansea SA9 1JW +44 (0)1639 849676 www.springdew.co.uk
Springdew Limited is a family-owned business, specialising in packaging services for the pharmaceutical, healthcare, veterinary and medical device markets. We commenced trading in 1992 and have, over the years, grown to over 60,000 square feet. We are based near Swansea, just off junction 45 of the M4. We are MHRA licensed for the primary & secondary assembly and packing of pharmaceutical products. We also hold ISO 13485 (Medical Devices) & ISO 9001 accreditations. We undertake full QP Release to Market and have 2 QPs on site We pride ourselves on our quality, flexibility, cost-competitiveness and speed-to-market. We are approved by several multi-national healthcare companies and have won several awards for our high levels of customer service. Our packaging services include: hand-assembly, embellishment, re-packing, inspection, carton and/or leaflet replacement, shelf-ready packing, high-frequency welding, blister-to-card sealing, clip-strip & gravity feed unit assembly, counter display unit assembly, over-labelling, RFID tagging, over-wrapping, shrink-wrapping, flow-wrapping, shrinksleeving and medical device assembly/packing. In addition, we have in-house vacuum forming facilities for clam and plastic tray production. This offers our customers high levels of flexibility and quick turnaround times.
Surgical Synergy Limited 156 Pentre Nicklaus Machynys Llanelli Carmarthenshire SA15 2DF +44 (0)1554 749303 ieuan.w.griffiths@btinternet.com
Company established to take innovative medical product design to market. Still at R&D stage, but projected to have first sales in 2015. Prototype development underway and next stages of testing and accreditation currently in planning.
SymlConnect Room 503 & 504 Institute Of Life Science 2 Singleton Park Swansea University Swansea SA2 8PP +44 (0)1792 60 6524 www.symlconnect.com info@symlconnect.com
28
SymlConnect, a specialised software design and development company, offers secure smart mobile solutions integrated with existing clinical systems for better clinical time management. Healthcare professionals can ‘retrieve & return’ the relevant confidential patient information from multiple systems with a single log in. Information collected via paper based forms can now be gathered electronically at the patient side, with best practice protocols and interactive alerts. Dynamic reports are made available for clinicians and managers. Patient to clinician remote confidential and secure communication is also being developed to address better post-operative monitoring and community care. The solutions improve patient care through improved outcomes whilst delivering cost efficiency.
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Synergy Health Laboratory Services Gavenny Court Brecon Road Abergavenny NP7 7RX +44 (0)1873 856688 www.synergyhealthplc.com/SHLS labservices.info@synergyhealthplc.com
Synergy Health Laboratory Services is a nationwide provider of fully accredited Drug and Alcohol testing services to clients in an extensive variety of industry sectors. Based out of a state-of-the-art laboratory in Abergavenny, Synergy Health manage the complete process, from sample collection to laboratory analysis. Synergy Health also provides a massive profile of CPA accredited general pathology testing that includes haematology, biochemistry, microbiology and trace metal testing.
Synidor Institute of Life Science School of Medicine Swansea University SA2 8PP +44 (0)7721 856324 www.synidor.com frank@synidor.com
Specialises in patient monitoring for immobility in beds and chairs.
The Electrode Company Limited 23 Medicentre Cardiff CF14 4UJ +44 (0)29 2068 2023 www.electro.co.uk lightman@electro.co.uk
The Lightman is a unique technology for checking the accuracy of pulse oximeter sensors. Simulators check functionality but do not check accuracy. Surveys have indicated that about 30% of sensors in use are so inaccurate that patients are at risk of inappropriate oxygen therapy and/or unnecessary and harmful interventions. Recently there has been a rise in the number of inaccurate pulse oximeter sensors in use and at the same time a user’s expectation and reliance on pulse oximetry is increasing. If sensor accuracy is not checked every decision influenced by that sensor has no foundation.
The Magstim Company Spring Gardens Whitland Carmarthenshire SA34 0HR +44 (0)199 424798 www.magstim.com info@magstim.com
Magstim provides the means for neuroscientists to work with the human brain in awake subjects by manufacturing and supplying state-of-the-art clinical and research instruments. Magstim and Neurosign products cover the fields of neurology, neurophysiology, psychiatry and cognitive neuroscience as well as ENT, orthopaedic and neurosurgery. Magstim maintains a strong commitment to R&D and product improvement. Collaborating with researchers in British and European major centres of expertise (as well as those in North America and Japan) ensures that Magstim remains informed about clinical and medical advances, enabling the company to develop products at the forefront of technology.
Time for Medicine Cardiff Medicentre Heath Park Cardiff South Glamorgan CF14 4UJ +44 (0)29 2075 7744 www.timeformedicine.com enquiries@timeformedicine.com
The company is a spin out from the University Hospital of Wales in Cardiff (UHW). The objective of this business proposition is to develop diagnostic software to replicate the skills of the best clinical consultants and perform the role of the specialist in diagnosing patients’ conditions. The company’s web based diagnostic interface will replace the need for patients to visit specialist consultants in large hospitals, with all the attendant waiting times and costs. Additionally the company is developing mobile platforms for the remote management of many chronic conditions. The company’s products are aimed at both the private market, i.e. direct to consumers over the web through the consumer brand MyDocforhealth.com, and the public market, through the NHS with the objective of significantly reducing costs whilst maintaining or improving service provision. The company has the backing of over 50 senior clinical consultants in Cardiff and other parts of the UK, The Cardiff and Vale University Health Board and the Welsh Government.
29
Theryte William Russell House The Square Lightwater Surrey GU18 5SS +44 (0)1276 855777 www.theryte.com crispin.kirkman@theryte.com
Theryte is a cancer drug discovery and development company. Its technology builds on a previously undescribed mechanism of action and is intrinsically selective to cancers whilst sparing normal human cells. Development is currently at the pre-clinical stage. Theryte’s experimental data suggest that there exists a relatively small number of key proteins which co-operate to exert a novel function in cancer cells, and by so doing re-stabilise the otherwise unstable cancer cell. A recent peptidomimetic compound shows significant anti-cancer activity against a range of solid tumour types and Theryte has embarked on a program of work to achieve in vivo proof of concept. Theryte outsources the majority of its R&D activities, and has requirements for medicinal chemistry, early ADME/Tox. studies, in vivo pharmacokinetics, tolerability and xenografts. In addition, the company is looking for collaborators and partners who can carry out cancer biochemical and genetics experiments to further investigate the novel mechanism of action.
Ultrawave Eastgate Business Park Wentloog Avenue Cardiff CF3 2EY +44 (0)845 330 4236 www.ultrawave.co.uk admin@ultrawave.co.uk
Ultrawave is one of the largest manufacturers of precision ultrasonic cleaning equipment in the UK. Producing over 50,000 ultrasonic cleaning systems since our formation in 1990, all our products are designed and built to the highest quality standards in Cardiff, Wales. Accredited to ISO13485 and ISO9001, Ultrawave has developed a broad range of ultrasonic cleaning systems across a wide range of industries throughout the world. Our client portfolio includes healthcare organisations as well as pharmaceutical, medical device and orthopaedic implant manufacturers, all of whom benefit from improved cleaning and reduced processing time with traceable and repeatable results. The HygeaÂŽ range of HTM compliant ultrasonic baths offers full cycle validation and is used for pre-sterilisation in dental practices, primary care and CSSD environments within both the NHS and the private sectors.
30
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Pharmaceuticals & Clinical Trials Services Biotec Services International Biotec House Central Park Western Avenue Industrial Estate, Bridgend CF31 3RT +44 (0)1656 750555 www.biotec-uk.com enquiries@biotec-uk.com Twitter: @BiotecServices
With over 15 years’ experience, Biotec has built a global reputation as a company with the commitment to quality and technical excellence required to support your clinical trials from Phase I to IV and onto commercial supply. Our purpose built, split-site facility supports multinational trials and the commercial launch of our clients’ products on a daily basis. Our services include: QP and GMP Consultancy, Clinical Supplies, GMP Temperature Controlled Storage, Global Logistics, Advanced Therapeutic Medicinal Products (ATMPS), Commercial Services. Biotec also handles containment level I and II Genetically Modified Organisms (GMOs), Schedule II to V controlled drugs, in addition to providing storage arrangements such as customs warehousing for a range of controlled temperatures from controlled ambient (15-25°C) down to -196°C. Biotec is relied upon by clients to deliver critical studies of various sizes, on time and on budget. Trust Biotec to be your international partner in clinical trials.
Martindale Pharma Martindale Pharma was established 140 years ago and has maintained focus on supplying medicines in areas of high unmet need. Over the last 3 years the business has been transformed by investment and expertise into an international Specialty Pharma company which operates in areas of medicine where demand is increasing and where healthcare systems in both developed and developing markets will fund medicines. Our portfolio focuses on: Building A2, Glory Park Glory Park Avenue Wooburn Green, Bucks HP10 0DF +44 (0)1628 551900 www.martindalepharma.co.uk/ neil.peters@martindalepharma.co.uk
Emergency care- through our Critical Care portfolio of differentiated sterile injection products which include first line treatments for cardiac arrest. Lifestyle diseases- through our Addiction and Wound Care portfolios tackling opioid dependence and chronic wounds such as diabetic foot ulcers.
Neem Biotech Unit 1-3 Willowbrook Technical Units St Mellons Cardiff South Glamorgan CF3 OEF +44 (0)29 2079 4796 www.neembiotech.com mgraz@neembiotech.com
Neem Biotech is a fully integrated medical and industrial biotech company with a focus on antimicrobial research in areas of high unmet needs and rare diseases. Other areas of focus include immunomodulation and metabolic diseases. Neem Biotech specialises in creating platform technologies based on bioactives from plant and marine sources. For example, the antimicrobial lead compound serves as a customisable platform for various applications such a targeting antibiotic resistant strains through synergistic quorum sensing inhibition and inherent antimicrobial activity. A similar platform technology approach applies to the other focus areas as well, whilst spin offs from this research lead to applications in other areas of human health, animal health and crop science. Neem’s outputs are scientifically and clinically validated active ingredients, for its internal pipeline or for third parties through contract research in natural compound extraction. Specialisms: Life Sciences, Biotechnology
Norgine Norgine Ltd is the UK-based affiliate of Norgine B.V., Norgine is an EU specialist pharmaceutical company which provides expertise and ‘know how’ in Europe to develop, manufacture and market products that offer real value to healthcare professionals, payers and patients. Norgine’s corporate office is based in the Netherlands and Norgine’s global operations are based in Harefield in the UK. Norgine has one R&D centre in Hengoed, UK and two manufacturing sites – one in Hengoed and one in Dreux, France. Norgine employs over 1,200 people globally. Tir-y-Berth, New Road Hengoed CF82 8SJ Hengoed Manufacturing: +44 (0)1443 812183 Clinical Supply Services: +44 (0)1443 865734 www.norgine.com
Norgine has a long standing expertise in gastroenterology but also operates in other specialist therapy areas such as hepatology, critical and supportive care. Also, Norgine offers contract research organisation (CRO) services for the supply of investigational medicinal products to clinical trials worldwide. Norgine finds and works with partners with complementary skills and a shared vision for improving healthcare to develop, manufacture and sell products that patients need.
31
Penn Pharma
Units 23-24 Tafarnaubach Industrial Estate Tredegar Gwent NP22 3AA +44 (0)1495 711222 www.pennpharm.com webenquiries@pennpharm.com
Penn Pharma has over 30 years of experience in providing integrated drug development, clinical trial supply, manufacturing and packaging services to the international healthcare industry. With a full range of contract services available, from preformulation, analytical and formulation development, through to clinical trial supplies, scale-up and commercial manufacturing, Penn is able to take compounds from the earliest stages of development through to commercialisation. It is this “molecule to market” offering from Penn that ensures true speed to market for our global client base. Recognised for our regulatory and export experience, Penn supplies many markets including Europe, the USA, South America and Japan. Our Knowledge and expertise, has enabled us to become the trusted partner for many of the world’s top pharmaceutical companies. In recent years, we have invested to expand our operations including a purpose-built contained manufacturing facility which opened in 2013 followed by a large-scale commercial manufacturing suite which became operational in 2014. With this significant expansion programme, we are now able to offer over 0.5 billion doses of capacity on site ranging from 1kg to 300kg scale for non-potent and 1kg to 120kg scale for potent molecules.
Protherics UK, a BTG International group company Blaenwaun Ffostrasol Llandysul Ceredigion SA44 5JT +44 (0)1239 851 122 www.btgplc.com info@btgplc.com
BTG is an international specialist healthcare company developing and commercialising products targeting acute care, oncology and vascular diseases. We are focused in three business areas: Interventional Medicine, Specialty Pharmaceuticals and Licensing. Interventional Medicine comprises Interventional Oncology and Interventional Vascular products including drugdevice combinations. Our Interventional Oncology products are used to treat patients with liver tumours, and our Interventional Vascular products are used to treat patients with severe blood clots and patients with superficial venous incompetence. Specialty Pharmaceuticals includes acute care antidotes to treat snake envenomation and toxicity associated with medicines used for heart conditions and cancer. Our Licensing business area comprises licensed products and programmes that generate significant royalties. To find out more about the BTG International group companies and our products, visit www.btgplc.com.
Quay Pharma Quay House 28 Parkway Deeside Industrial Park Deeside CH5 2NS +44 (0)1244 837000 www.quaypharma.com enquiries@quaypharma.com
Quay Pharma is a leading provider of contract development and manufacturing services to the pharmaceutical and biotech industry. From Quay Pharma’s facility North Wales (Deeside), the experienced team works with clients to develop a range of pharmaceutical products.
Ruskinn Technology Ltd 8-9 York Park Bridgend Industrial Park Bridgend CF31 3TB +44 (0)1656 645988 www.BakerRuskinn.com ruskinoffice@ruskinn.com
Ruskinn Technology Limited is a world leader in the manufacture and supply of anaerobic and modified atmosphere workstations. Ruskinn is a division of The Baker Company of Sanford, Maine USA, a pioneer and world leader in Biological Safety Cabinets. Ruskinn has over 2000 workstation installations in more than 40 countries. The company and production centre is located in its own purpose built manufacturing facility in Bridgend, South Wales, UK.. Ruskinn’s range of high quality workstations is available worldwide through a global network of carefully selected distributors. Stem Cell Investigations Stem cells continue to show massive potential for regenerative medicine. To ensure researchers can realise this potential, the SCI-tive workstation range from Ruskinn has been specifically designed to enable both embryonic and adult stem cells to be isolated and differentiated under optimum atmospheric conditions. Working under controlled conditions is essential to ensure the differentiation process does not result in inappropriate cell types. Furthermore, the cell differentiating process can be studied with integrated microscopy and digital software. Microbiology Ruskinn’s range of anaerobic workstations are designed specifically to help microbiologists to cope with rising workloads. From the “personal” Bugbox with a capacity of 280 plates to the “ultimate” Concept 1000, you will find the ideal workstation for your laboratory. Cell Biology
32
Ruskinn’s range of hypoxic workstations allow researchers to study even the most complex of cell interactions under perfect hypoxic or anoxic conditions. Oxygen, Carbon dioxide, temperature and humidity can be precisely controlled to create the perfect environment for all experiments. The advanced ergonomic design then enables rapid single plate loading, comfortable hand access and flexible use of a wide range of accessories.
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Simbec-ORION Group Ltd Merthyr Tydfil Industrial Park Cardiff Road Merthyr Tydfil CF48 4DR +44 (0)1443 694309 www.simbec.com christine.mortimer@simbec.com
SIMBEC-ORION is full service international Contract Research Organisation (CRO) with capabilities in both Early Stage Clinical Development, first in human healthy volunteer and patient trials and Late Stage Clinical Development, with deep expertise in oncology and rare and orphan diseases and studies involving Ophthalmology, Dermatology and Gamma Scintigraphy imaging. The Group employs approximately 250 staff and has operations across Europe, Australia and the United States together with capabilities in multiple other territories. With headquarters in the UK based in Merthyr Tydfil, South Wales, SIMBEC-ORION offers large and mid-cap pharmaceutical and biotech clients a complete service offering from first in human exploratory clinical pharmacology studies, through Phase II and Phase III studies. In addition, the Group offers its clients Phase IV Post authorisation studies for marketing, observational and post authorisation safety studies (“PASS”). Our studies are complemented by in-house dedicated Central Laboratory Facility (Bioanalytical And Pathology) for rapid, accurate and reliable sample analysis.
TrakCel Limited 11 Raleigh Walk Brigantine Place Cardiff CF10 4LN +44 (0)29 20483729 www.trakcel.com matthew.lakelin@trakcel.com
TrakCel is a Clinical Orchestration Platform designed to efficiently safeguard patients and orchestrate processes across regenerative and cell-based therapies. TrakCel’s focus is on ensuring that the right patient gets the right therapy at the right time in a scalable and efficient way. For both autologous and allogeneic matched donor therapies, TrakCel orchestrates the movement of the patient’s/donor’s cellular starting material from the patient to a processing/ manufacturing facility and back to the patient for engraftment. TrakCel’s patented, Biometric-based technology efficiently records, tracks and reports all aspects of the ATMP supply chain from Patient registration and collection of cells, through Logistics, Storage, processing of the cells in Manufacturing and delivery back to the cell donor.
Packaging Coordinators Inc (PCI Services)
Wye Valley Business Park Hay on Wye Hereford HR3 5PG +44(0)1497 820829 www.pciservices.com info@pciservices.com
PCI is a global leader for packaging services, supporting our customers in each stage of the development and commercialisation of drug products. A trusted partner to the world’s largest and most successful pharmaceutical firms, we offer services from early phase clinical studies to commercial launch, and ongoing supply. We partner with manufacturers, offering insight and expertise, combined with innovative technologies and an uncompromising commitment to exceptional service and quality. PCI features 14 cGMP packaging, storage, and distribution facilities across two continents audited by both the MHRA and FDA. Our highly trained associates are dedicated to meeting the needs of our customers, establishing lasting relationships with our customers through proven performance and providing exceptional service throughout the life of a project. Our insight and expertise in commercialising new medicines and knowledge in global markets affords us opportunities to partner with leading pharmaceutical and biotech companies in bringing lifesaving medicines to patients and improving health outcomes.
Q Chip Oddfellows House 19 Newport Road Cardiff CF24 0AA +44 (0)29 2048 0180 www.q-chip.com ddp@q-chip.com
Q Chip, a drug-delivery company, is developing Q-Sphera™, a tuneable sustained release technology platform for peptide and small-molecule therapeutics. Q-Sphera products are injectable formulations of bioresorbable microspheres containing active pharmaceutical ingredient (API), designed to provide predictable drug-release from a single injection, over several weeks or several months. The Q-Sphera platform enables: Product uniformity, scalability and control High API loading and encapsulation efficiency for hydrophilic, hydrophobic, cationic and anionic compounds Fast and inexpensive formulation development Low cost aseptic manufacturing at Phase I and Phase III scales with minimal footprint Q Chip’s lead product is Q-Octreotide, an improved once-monthly formulation of octreotide acetate for the treatment of acromegaly.
33
Sharp Clinical Services (UK) Waller House, Elvicta Business Park, Crickhowell NP8 1DF +44(0)1873 812182 www.sharpclinical.com saleseurope@sharpclinical.com
Sharp Clinical Services is a leading provider of clinical supply chain services including product development and manufacture, packing, labeling, storage & distribution and QP audit and release services. Our experienced project management and operational teams bring together years of experience in producing and managing your clinical supply chain across the Globe. All projects are compliant with the highest quality standards spanning Good Manufacturing Practices (cGMP), Good Distribution Practices, and all international regulatory requirements. With Sharp Clinical Service’s experience of managing local and global clinical supply chains, access to the world markets just became easier from clinical production, labelling & distribution to comparator sourcing & EU Qualified Person (QP) audit and release services. We are big enough to deliver your global project while remaining small enough to care for your product like our own. MHRA licensed facility conforming to the EU clinical trials directive, Sharp Clinical Services has the capability to: Manage the complete manufacturing and distribution needs for all trial phases, Manage solid, semi-solid and large molecule clinical trials materials, Import drug under MHRA wholesaler dealers’ license, Support the preparation of the Investigational Medicinal Product Dossier, QP services including supply chain audits and declaration, QP importation and batch certification and clinical batch release to the trial, Manage controlled drugs for clinical activity under Home Office CD License, Specialised distribution, retrieval and destruction of IMP and clinical material, Audited depot network to support global distribution
World Courier
Unit 1 New Road New Inn Pontypool NP4 0TL +44 (0)7818422978 www.worldcourier.com/ dspillett@worldcourier.co.uk
34
Incorporated in 1969, World Courier is the leader in specialty logistics for the global life sciences industry delivering fully-integrated GxP-compliant temperature-controlled transport, storage and distribution solutions worldwide in over 10.000 clinical studies. World Courier has a network of over 150 company offices operating in more than 50 countries plus a network of 13 x GMP compliant storage depots in strategic locations. The latest addition to the World Courier network is a purpose build facility in South Wales. Through its company-owned network of offices World Courier provides door-to-door, customs-cleared service to more than 220 countries and territories and set the benchmark for temperature controlled, time sensitive transportation. As Cold Chain shipments face increased scrutiny from internal bodies and international agencies alike, strict adherence to temperature control is critical for compliance with international regulatory, manufacturing and safety standards. With our proven track record in Cold Chain Management, World Courier is the only specialty logistics provider that offers comprehensive and customized temperature-controlled transportation services 24/7/365 worldwide.
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
NHS, Contract Research & Testing Abertawe Bro Morgannwg University (ABMU) Health Board R&D Department Morriston Hospital Swansea SA6 6NL +44 (0)1792 704056 abm.rd@wales.nhs.uk
Abertawe Bro Morgannwg Health Board provides primary and secondary healthcare services mainly for the 600,000 residents of Bridgend, Neath Port Talbot and Swansea. The Health Board has four acute hospitals providing a range of services: Singleton and Morriston Hospitals in Swansea, Neath Port Talbot Hospital in Port Talbot and the Princess of Wales Hospital in Bridgend, and is responsible for providing a number of specialist regional services including cardiac, burns and plastic surgery, and neonatal. Forensic mental health services are provided for the whole of South Wales, while learning disability services are provided from Swansea to Cardiff. A range of community based services are also delivered in patients’ homes, via community hospitals, health centres and clinics. The Health Board contracts independent practitioners in respect of primary care services, which are delivered by GPs, opticians, pharmacists and dentists. The University Health Board is committed to R&D and is a partner of Swansea University’s ILS and ILS2 developments. We have dedicated clinical trial teams and facilities, enabling collaboration with academic and business partners on research programmes across all clinical specialities.
Aneurin Bevan Health Board - Intellectual Property Group Intellectual Property Group The R&D Dept The Friars Friars Road Newport NP20 4EZ +44 (0)1633 656353 abb_r&d@wales.nhs.uk
The Aneurin Bevan University Health Board wishes to encourage and enable staff to participate in the generation and exploitation of intellectual property as an integral part of its commitment to delivering the best possible standard of patient care. It is the responsibility of the IP Group to manage and protect IP for the Health Board. The Group comprises Dr Chris Edwards, Consultant Medical Physicist (Chair), Dr Tan Mian (Consultant Anaesthetist), Dr Iljaz Hodzovic (Consultant Anaesthetist), Susan Hallybone ( Medical Risk Manager), Mel Laidler (Aneurin Bevan Continuous Improvement Programme Manager) and Laura Galligan (Research Officer). In order to encourage innovation within the Health Board, our IP Policy offers a generous scheme for financing IP protection and sharing royalty or other income with the inventor.
Betsi Cadwaladr University Health Board Research & Development Office Holywell Community Hospital Halkyn Road Holywell Flintshire CH8 7TZ +44 (0)1352 718382 www.bcu.wales.nhs.uk/ lona.tudorjones@wales.nhs.uk
Betsi Cadwaladr University Health Board provides a full range of primary, community, mental health and acute hospital services for a population of around 676,00 people across the six counties of North Wales (Anglesey, Gwynedd, Conwy, Denbighshire, Flintshire and Wrexham) as well as some parts of Mid Wales, Cheshire and Shropshire. The Health Board has three acute hospitals; Ysbyty Gwynedd, Ysbyty Glan Clwyd and Wrexham Maelor Hospital. The Health Board actively supports a varied and dynamic research agenda and works with local industry to support the national agenda of increasing both health and wealth in Wales. It encourages staff to develop innovative and creative approaches to the delivery of health care that can be further developed with partners in academic, industry and health care settings and with active engagement with the all Wales NISCHR infrastructure. The Health Board provides industry and business partners opportunities to work with mental health, acute, community and primary care services delivered by general practices, dentists, opticians and pharmacists.
Cardiff University - Anaesthesia Innovation Heath Park Cardiff CF14 4XN +44 (0)29 2074 2575 www.walesanaesthesia.wordpress.com/ clarkj11@cardiff.ac.uk
The Bill Mapleson Centre is a medical innovation business. It is run by senior academics and clinical consultants from Cardiff University’s Department of Anaesthetics, Intensive Care and Pain Medicine, putting all profits back into Cardiff University. The Centre has extensive expertise in design, development and evaluation of medical devices used in anaesthesia, respiratory medicine and intensive care using laboratory-based tests, user assessments and clinical trials. We collaborate extensively with the NHS and industry in developing innovative solutions to clinical problems, and successfully attract major innovation funding. We offer clinical and academic advice to industry during the development of novel products. In addition we provide training and educational events incorporating a broad range of simulation scenarios.
35
Cardiff University - Wound Healing Research Unit (WHRU)/WWII Ltd School of Medicine Upper Ground Floor Room 18 Heath Park Cardiff CF14 4XN +44 (0)29 2074 8293 www.whru.co.uk info@ welshwoundinnovationcentre.com
Wales has a significant ‘core competence’ in wound healing, including clinical and economic leadership. The most regionally and globally recognised part of this leadership is The Wound Healing Research Unit (WHRU) which was established in 1991 as the very first research unit to specialise in wound healing. Since then the WHRU has continued to lead the world in this clinical area. Based at the University of Cardiff (UHW site) and working closely with the University Hospital. The WHRU collaborates closely with a host of regional, national and international organisations, including companies, other researchers and health care providers. It has assisted in knowledge transfer projects which have brought many pioneering new products and technologies to the market, benefiting patients, globally with some research being in the image management, storage, manipulation/computation arena. With the use of the current WHRU as central expertise focus, the creation of the Welsh Wound Innovation Initiative is a model for a network of clinical centres of excellence in wound care both nationally and internationally. The current WHRU is the basis for the larger all Wales organisation growing into an expanded, not-for-profit business, based at the Welsh Wound Innovation Centre in Llantrisant. The Welsh Initiative is funded by the Welsh Government and Welsh National Health Service and is used as an example of innovation leadership by both the Welsh and British Governments.
Cardiff and Vale University Health Board - Medical Physics and Clinical Engineering University Hospital of Wales Heath Park Cardiff CF14 4XW +44 (0)29 2074 2014 www.cardiffandvaleuhb.wales.nhs. uk/ john.maisey@wales.nhs.uk
Our clinical medical physics services include medical imaging, vascular (Doppler) ultrasound, nuclear medicine, bone densitometry and body composition determination. We have a dual-head gamma camera system for planar radionuclide imaging and single photon emission tomography; this incorporates an x-ray CT scanner. Other major items of equipment and facilities include a radiopharmacy (for the production of sterile radioactive products), dual-energy x-ray absorptiometers, duplex ultrasound scanners, a niche magnetic resonance imager, a whole body gamma radiation counter and a range of other radiation detectors. We have expertise in protection against both ionising and non-ionising radiation. In clinical engineering we provide a wide range of equipment management services covering the life-cycle of medical and related equipment. Our mechanical engineering section designs, develops and produces medical devices to take forward collaborative research ideas in a variety of medical specialties. We would welcome opportunities for further research and development collaborations in the above areas.
Cedar Healthcare Technology Research Centre Cardiff Medicentre Heath Park Cardiff CF14 4UJ +44 (0)29 2074 4771 www.cedar.wales.nhs.uk uhw.cedar@wales.nhs.uk
Cedar is a Healthcare Technology Research Centre, able to support decision making in healthcare by providing research evidence on the clinical effectiveness and economic impact of emerging health technologies, medical devices, diagnostic tests, healthcare interventions and NHS service configuration. Established in 1977, Cedar is part of Cardiff and Vale University Health Board (UHB) and Cardiff University School of Engineering’s Biomedical Engineering Research Group. The Swansea Centre for Health Economics (SCHE) and Swansea University Health Informatics Research Unit (HIRU) are also within the Cedar consortium. Cedar has a contract with the National Institute for Health and Care Excellence (NICE), working in the Medical Technologies Evaluation Programme (MTEP). In addition to its work for NICE, Cedar is able to apply for research grants and undertake bespoke work for other organisations. Cedar works to a quality system that is accredited to BS EN ISO 9001:2008 and has expertise and experience in: Systematic evidence review – literature searching and critical appraisal. Project management. Stakeholder engagement. User assessments. Developing and validating Patient Reported Outcome Measures (PROMs). Standards testing for medical/ consumer health devices. Running clinical trials of medical devices. Health economics. Report writing. Specialism Biotechnology, Clinical Organisations, Diagnostics, Medical Technology
Cwm Taf University Health Board Research and Development Department Royal Glamorgan Hospital Ynysmaerdy Llantrisant Rhondda Cynon Taf CF72 8XR +44 (0)1443 443421 www.cwmtafuhb.wales.nhs.uk/ CTUHB_RD@wales.nhs.uk
Cwm Taf University Health Board gained university health board status in December 2013. We provide an extensive complement of clinical services to a population of circa 300,000 people across Merthyr Tydfil and Rhondda Cynon Taf with a variable socio-economic and health demographic. It is the second most densely populated health board area in Wales. Clinical services are also provided to the people of south Powys, north Rhymney, north Cardiff and other adjacent health community areas. In addition, some specialist services are provided to the wider catchment area in south Wales. Acute, intermediate, community and mental health services, to include child adolescent mental health services are delivered across a network of community clinics, health centres, health parks, community hospitals and two district general hospitals. We have an existing strong and well established collaborative research portfolio in anaesthetics, mental health, public health, ENT, respiratory medicine, vascular surgery, paediatrics, diagnostics and primary care. We have ambitious strategic objectives aligned to local, regional and national research priorities. Through the continuous development of our research and development infrastructure, we actively seek opportunities to develop collaborative partnerships with industry and academia across all clinical specialties and the life sciences sector. Our aim in doing so is to facilitate the delivery of a high quality, innovative, patient centred commercial and non-commercial research agenda.
36
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Health Research Wales 2nd Floor, 12 Cathedral Road Cardiff CF11 9LJ +44 (0)29 2023 0457 www.healthresearchwales.com contact@healthresearchwales.com
Health Research Wales has been established to provide a one-stop source of information and support for companies wishing to undertake clinical research in Wales. Our mission is to facilitate the successful delivery of commercial research in the NHS and promote Wales as an effective place to do research. Health Research Wales provides a number of services to facilitate the effective set-up, management and delivery of commercial clinical research in Wales. These include: General Signposting, Partnering, Costing Advice & Support, Feasibility, Co-ordination, Contracts Advice & Support, Study Set-up & Management, Performance Monitoring.
NISCHR AHSC South Wales Regional Hub Swansea University College of Medicine Institute of Life Science 1 Singleton Park Swansea SA2 8PP +44 (0)1792 295505 N.Dale@swansea.ac.uk
NISCHR AHSC - Regional Hubs to promote collaborative working between Academia, NHS and Industry Core statement: 1. To facilitate the integration of Research, Education and Health Services to improve the health and
well-being for the people and economy of West Wales. 2. To develop partnerships between Academia , Care Services and Businesses in, and attached to West Wales. 3. To promote public engagement in Research, in Education, and Health Services for better health gains and more prudent healthcare.
North Wales Organisation for Randomised Trials in Health (NWORTH) Meirion Building, Normal Site, Bangor University, Hollyhead Road, Bangor, Gwynedd LL57 2PZ 01248 388095 K.Mawdesley@Bangor.ac.uk www.bangor.ac.uk/imscar/nworth
The North Wales Organisation for Randomised Trials in Health and Social Care (NWORTH), the Bangor Clinical Trials Unit, specialises in the design, conduct, analysis and reporting of clinical trials and other health related research. Our mission is to improve the health and well being of the people of Wales and beyond by evaluating complex interventions in health and social care, and to advance the theory and practice of randomised control trials and other rigorous designs for evaluation. In recent years we have been working closely with Betsi Cadwaladr University Health Board (BCUHB) to develop new methodologies to promote and facilitate cooperation on medical research to make the set-up, data gathering and administration of clinical trials more efficient and thus quicker and more robust, and to thus enhance the research capabilities of the two organisations. Ultimately, the purpose of these innovative initiatives is to develop an environment whereby BCUHB and NWORTH are seen jointly as a centre of excellence for evidence based health research and are recognised throughout the health research sector as an exceptional place in which to conduct medical research.
Surgical Materials Testing Laboratory Princess of Wales Hospital Coity Road Bridgend CF31 1RQ +44 (0)1656 752820 www.smtl.co.uk info@smtl.co.uk Twitter: @SMTLab
The Surgical Materials Testing Laboratory, part of the Welsh NHS, provides a range of testing and technical services to the NHS and the medical device industry worldwide, including but not limited to: Physical and biological testing of disposable medical devices to national and international standards; Dressings testing (fluid handling and affinity, conformability, to BP and BS requirements) and bandage testing to BS 7505; Biological testing (cytotoxicity testing to ISO 10993-5, protein testing to EN455-3; Hosiery testing to BS 6612, 7672 and 7563 and glove testing to EN 455; Microbiological testing, including bioburden, endotoxin, barrier and antimicrobial testing (e.g. silver dressings); Environmental monitoring of cleanrooms (to ISO 14644-1 and GMP); Surgical instrument evaluations (single use and reusable); Test method development, R&D and incident investigation. SMTL is UKAS accredited to ISO 17025 for test laboratories.
37
Professional Services and Suppliers Abel & Imray
3 Assembly Square Britannia Quay Cardiff CF10 4PL +44 (0)29 2089 4200 www.patentable.co.uk ai@patentable.co.uk
Abel & Imray is a leading firm of Patent and Trade Mark Attorneys handling all aspects of intellectual property including patents, trademarks and designs. We have expertise in all fields of medical and related technology. Our team of biotechnology and chemistry specialists has particular experience in diagnostics, gene therapy, drug delivery systems, protein engineering, pharmaceuticals and combinatorial chemistry. We have extensive experience of medical imaging technology and medical devices, including mechanical, optical and electronic medical devices. Our professionals can help you protect and exploit your intellectual property relating to those fields, as well as help you manage and develop your intellectual property portfolios.
arche life sciences 10 Bradenham Place Penarth Vale of Glamorgan CF64 2AG +44 (0)7986 484898 www.archelifesciences.com mark.bowman@archelifesciences.com
arche life sciences is a professional services firm offering specialist consultancy to startup companies operating in the life sciences sector. The founder, Dr Mark Bowman, is an expert in early-stage companies, with over fifteen years’ direct experience of identifying, launching, financing, and incubating technology-based startups. In addition to his academic qualifications, Mark is professionally qualified, holding both a CFAUK Investment Management Certificate and PRINCE 2 Practitioner status. Dr Bowman is an entrepreneurial self-starter who is able to work independently or lead teams. Experienced in strategic planning, corporate development, and business transformation, he is a people person, whose experienced communication style builds client confidence and trust within complex, deal-making environments.
ARP Associates Glen Rosa Developing businesses – developing people: we believe that there are two key strands to any business – hard-edged Llanellen business management and the softer, but crucial development of people. It is often difficult to get the balance right – Abergavenny particularly in scientific businesses, and especially where investment makes tough demands on performance. Monmouthshire NP7 9HF ARP Associates provides both elements to help develop company potential. Alison Payne coordinates the ARPAL team +44(0)7713 484870 and provides services in business development. The people development services are provided by a number of associates arpayne@arpaltd.co.uk with complementary skills and approaches, so we can ensure that we provide the right match for you – whether as coach, mentor, facilitator or trainer.
We have a hands-on approach to business development, so if you need additional support – whether long term or interim – we can help. We’d be pleased to have a chat, with no obligation, so why not give us a call and see what we can achieve together? Bevan & Buckland Langdon House Langdon Road Swansea Waterfront Swansea SA1 8QY +44 (0)1792 410100 www.bevanbuckland.co.uk mail@bevanbuckland.co.uk
Bevan & Buckland are a leading firm of Chartered Accountants based in South Wales. A key focus of our business is providing pro-active tax advice to companies and individuals. We have a particular specialism in the following areas: Research & Development tax relief - Our R&D tax team have assisted many companies maximise their R&D entitlement. This not only includes owner managed businesses, but also university spin outs, FTSE 100 companies and large international groups, and we have a particular specialism in working with companies in the life science sector. The head of our R&D tax team is also a member of HMRC’s R&D Consultative Committee, and thereby has invaluable insight into the operation of this relief; Patent box tax regime - a 10% effective tax rate which can apply for profits derived from qualifying patents; Tax incentives for individuals who invest in companies, including EIS and Seed EIS; Tax incentives for company employees, including EMI; and Succession and exit planning
38
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
BIC Innovation Pencoed Technology Centre Bridgend Bridgend CF35 5HZ +44 (0)1656 861536 www.bic-innovation.com info@bic-innovation.com
As one of Wales’ leading innovation consultancies, we work with our life science clients to help them innovate, exploit and commercialise their ideas. Our innovation methodology is designed to create an innovative culture as well as a pipeline of exploitable ideas which can be taken to market. We use our strong project and quality management skills and techniques, gained in a variety of manufacturing and service organisations, to minimise risk for our clients and reduce time to market. Our life sciences team has worked with leading global companies as well as SMEs, academia and research organisations. From incubating new ideas, to launching new products, BIC Innovation can project manage the whole process, or inject creativity at any point along the way. Our project teams offer a range of specialist skills, helping our clients to achieve their growth ambitions: Strategic innovation, New product development, Commercialisation of IP, Design, Supply chain development and management, Strategic marketing, Marketing communications, Marketing research, Sales and business development, Project management (including Prince 2), Management Information Systems design and implementation, HR development BIC Innovation also run a number of high profile programmes on behalf of Welsh Government and the EU, including the Workforce Development Programme, High Potential Starts and Enterprise Europe Network. BIC Innovation is a partner of PERA and the Wales Lead for the UK Innovation Forum.
Blackwood Embedded Solutions Britannia House – Suite G Caerphilly Business Park Caerphilly CF83 3GG +44 (0)2921 202098 wendy.giles@ blackwoodembeddedsolutions.co.uk www.blackwoodembededsolutions.co.uk
Blackwood Embedded Solutions Ltd specialises in full design cycle real-time embedded system design, both electronics and software. With a small team of engineers from graduates to experienced consultants, we can provide services from initial design concepts and prototypes, through specification, design, implementation, risk analysis/FMEA, verification and validation. We can offer 25+ years’ experience in medical device design and our recent projects include drug delivery systems, surgical generators and diagnostic medical products. We provide electronic design services including schematic capture, circuit simulation and PCB layout with Proteus design tools and hand-built engineering build prototypes. We also provide software design services for various microcontrollers: ARM, PIC, Fujitsu, Hitachi / Renesas including real time bare-metal software coding (or with operating systems) and removal of SOUP. Programming languages offered include C, C++, C# and Assembler.
Broomfield & Alexander Ty Derw Lime Tree Court Cardiff Gate Business Park Cardiff CF23 8AB +44 (0)29 2054 9939 www.broomfield.co.uk/sectors/ life-sciences/ info@broomfield.co.uk
Broomfield & Alexander are Wales’ leading independent firm of accountants and professional advisors, based in Cardiff, Newport and Swansea. We provide financial and commercial services to owner managed businesses, mid to large corporates, medical practices, private clients and professional practices. As a company in the life science industry, you are facing unprecedented demands with tighter financial constraints and increased regulatory requirements. These demands take you away from your core focus. Our specialist team at Broomfield & Alexander understand your challenges and can help you at every stage of your company’s development. In securing sufficient capital to grow your company, increasing operational efficiencies and reducing costs, taking your product to market, or meeting increased regulatory demands, we can guide you through the minefield of making the right decisions now and for your future. In addition to the traditional tax and accounting services, Broomfield & Alexander also assists our Life Sciences clients with services spanning the entire development cycle of companies, including: Funding and raising finance, including grant funding, Research & Development tax relief, Tax planning, Acquisitions, Tax efficient structures, Exit / Succession planning
Cadarn Consulting 34 Plas Y Mynach Radur Cardiff CF15 8GB +44 (0)7971 907747 www.cadarn.net/
CADARN Consulting is a technology, finance and management consultancy.
39
Cardiff Medicentre Heath Park Cardiff CF14 4UJ +44 (0)29 2075 7744 www.cardiffmedicentre.co.uk enquiries@cardiffmedicentre.co.uk
Cardiff Medicentre is a dedicated medtech and biotech business incubator located on the University Hospital of Wales campus. The latter extends across 53 acres, provides a working base for over 4,000 people and is home to Cardiff University’s School of Medicine. The Cardiff Medicentre was officially opened in 1994 and was the first incubator of its kind in the United Kingdom. It provides high quality office and laboratory accommodation comprising of 32 units ranging from 284 sq ft to 1,045 sq ft. Low-cost desk leasing facilities are also available to encourage entrepreneurs to enter the Cardiff Medicentre community whilst writing business plans and raising finance.
CLEARTECHLive 7-10 Stadium Close Cardiff CF11 8TS +44 (0)29 2067 8000 www.cleartechlive.co.uk ben.voisey@cleartechlive.co.uk
CLEARTECHlive your technical solutions and event production company. We operate mainly in the medical and bio-science sectors and we specialise in product marketing through live surgery filming and live web stream or satellite broadcasting to training theatres and university hospitals. We design and supply exhibition stands across the UK and Europe as well as setting up and technically managing; conferences, symposiums, sales meetings, video production and editing, product manufacture and demonstration videos. Our clients consist of end user, manufacturer, pharma events companies, direct sales departments and training providers. We have many years experience within the sector and are able to provide a national and international service from our base in Wales at very competitive rates. We attend major medical and bio-science events across Europe and the USA - so if we can help please call. If you are planning meetings or events we can talk to you about the latest technologies to enable maximum return on your marketing and sales investment. You can talk to one of our experienced project managers on 029 20678000.
Contact Group Haigh Avenue Whitehill Industrial Estate Stockport SK4 1NU +44 (0)161 480 3568 www.contact-group.co.uk tonysweeney@contact-group.co.uk
Contact Group, design and manufacture and supply Pharmaceutical cartons with Braille, Mock Ups and associated leaflets, Booklets and Manuals. We duplicate and print CD and DVDs. We have a Global Kitting and Supply Chain Facility in Hungary serving the Bio-Diagnostics, Pharmaceutical and Electronics sectors. We specialise in assisting Start-Up Businesses. We also have a Sister company which manufactures Printing Plates. We have a number of customers throughout Wales and USA.
Contact Innovation Contact Innovation, through its dedicated specialists, provides integrated strategic marketing, innovation and graphic design services to SMEs, start-ups and business support organisations. Our services are aimed at reducing financial risk, time to market and improving the quality of products and the chances of success for our clients. We do this by using up-to-date techniques as well as those that are tried and tested, combining them to provide a truly bespoke service for every client. Contact Innovation has extensive experience in the area of knowledge transfer - the transfer and utilisation of knowledge and technology developed by university and public research establishments for the benefit of private sector companies. 7 Schooner Way Atlantic Wharf Cardiff CF10 4DZ Wales +44 (0)29 2047 3456 www.contactinnovation.com gtudor@contactinnovation.com
40
Contact Innovation has worked for both private sector manufacturers, a university, and a government funded advisory service.
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Copia QA Ltd 4 Llanquian Close Cowbridge Vale of Glamorgan CF71 7HQ +44 (0)1446 776881 David.broderick@yahoo.co.uk
Copia QA is a medical device consultancy formed by David Broderick who has over 20 years experience of medical devices in both the quality and regulatory fields. Experience has been gained in areas including 510(k) submissions, Technical File compilation, risk management, supplier controls - including extensive experience in supplier auditing, CAPA, ISO 13485 implementation, IEC60601 - medical electrical devices, FDA remediation work, internal auditing, validation, design controls etc. He has also carried out several value creation projects which have resulted in significant cost savings. David has an initial Honours Degree in Metallurgy and Materials Science, he also has an MBA from the Open University.
Designworks Windsor Unit 2 The Windsor Business Centre Vansittart Estate Windsor Berks SL4 1SP +44 (0)1753 842404 www.designworksgroup.net jez@designworkswindsor.co.uk
Designworks is a product design and development company. We have been in business for over twenty years, and have development centres in the UK and Australia, with a manufacturing/sourcing/development team in both Hong Kong and Shenzhen. We specialise in delivering new products from concept through to production in a range of areas from medical devices, consumer goods, automotive products and childcare products. We also have experience of TSB, ECAS and CCF grant funding. Our in house team can develop concepts via the following methods: Insightful discovery work identifying market opportunities, and uncovering consumer needs and opportunities Concept sketches and computer generated illustrations Styling and ergonomic studies via computer generated imagery and scale models Outline CAD layouts of new concepts for feasibility and cost studies Electronics design, prototypes and sampling Working prototypes/models for demonstration and trials. Biocompatible materials available Documented manufacturing suitable information Assist in clinical trials and testing procedures via DW preferred partners Designworks is happy to assist in any of the above on an individual stage basis, or on a complete project solution. We provide fixed prices where possible and assign all IP that is derived from commissioned work to the client.
Dzaleta Consulting 65 Market Building 191-195 High Street Brentford TW8 8LB +44 (0)20 8560 6828 www.dzaletaconsulting.com/ maria@dzaletaconsulting.com
We provide business development support to companies interested to explore how they might exploit most potential from their assets outside of their core market. Seasoned scouts we seek out partners and can evaluate, negotiate and champion deals to close. Our geographic expertise covers all global territories outside of N.America. We have an in depth knowledge of the rapidly growing emerging markets (inc Russia / CIS, China, India, Latin America, SE Asia, MENA) as well the European Union. We draw on a bank of senior level business development and commercial experience gained across big-pharma, medium and start-up sized companies. We know what big-pharma looks for and what switches it off so can showcase your asset in a way that whets the appetites of commercially focussed decision makers. We scrutinise markets to find the best possible partner for you, with our extensive personal networks we can act as a door-opener and interface between you, the innovator, and potential licensors. We work flexibly to develop a partnering process that suits your needs and drive it to a successful close. Services include: Commercial due diligence, Commercial data analysis, Market scoping and asset evaluation, Financial modelling, Deal term analysis, Deal negotiation
41
Elite Electronic Systems Limited
Lackaboy Industrial Estate Tempo Road Enniskillen Co. Fermanagh BT74 4RL +44 (0)28 6632 7172 www.elitees.com info@elitees.com
Established in 1986, Elite now employs approximately 250 people across two locations; Enniskillen, Northern Ireland and South Carolina, USA. Elite is a leading EMS provider to a diverse customer portfolio of innovative and successful companies in Ireland, UK and internationally. Customers include those from Medical, Audio, Industrial and Power Generation industries. Elite employ experienced management, engineering and purchasing personnel, a highly trained / multi-skilled workforce and utilise state-of-the-art equipment to provide complete turnkey manufacturing, excellent quality and flexible scheduling. Elite are accustomed to accurately populating complex, high density boards, their subsequent test and final assembly. Workmanship is to IPC 610 Class 3 as required and is an authorised UL manufacturer. In 2012 Elite Electronics achieved its ISO 13485 Accreditation for the manufacture of medical devices. Elite offers each customer a tailored service with the aim of becoming an extension of their core business activities. This is evident in examples of customers who specialise in product development and sales/marketing; Elite is capable of handling purchasing, manufacturing, testing and distribution. Each customer has varying requirements so it is our aim to work closely with the customer to find out the most efficient process and tailor our service. Elite Electronic Systems: Elite is the largest independent CEM in Ireland, Elite has a major programme of investment for expansion, Elite has considerable spending power with suppliers, delivering cost savings, which are then passed on to our customers, Elite has a highly skilled, experienced workforce- trained to IPC 610 and IPC 620 Standards, Elite has state of the art equipment, Elite has in-built flexibility to move seamlessly between jobs and clients, Elite offers multiple options on testing, creating a bespoke testing solution for each customer, Elite has a production line dedicated to NPI and Prototyping, Elite has a wholly owned facility in the USA offering each customer a unique opportunity to “Assemble in the USA”, Elite has ISO9001:2008 and ISO13485 Quality accreditation, Elite is financially stable.
Ensinger Precision Engineering Wilfried Way Tonyrefail Mid Glamorgan CF39 8JQ +44 (0)1443 678500 www.ensinger.co.uk marktipton@ensinger.co.uk
Ensinger Precision Engineering Ltd (EPE) is at the forefront of precision machining technology in engineering plastics. The Company is highly focused on application engineering and works closely with customers on a technical level assisting in developing applications, specifying materials and optomising parts for manufacture. From our factory in South Wales we offer machining (2-, 3- and 5- axis turning and milling), finishing, kitting, polishing, part marking, assembly, testing and cleaning of plastics to customer specified requirements. EPE are accredited to ISO9001:2008 and ISO13485:2003 standards in addition to holding investors in people status. EPE are part of the Ensinger worldwide group of companies. Specialties: Machining (2,3,5 axis milling & turning), Application Engineering, Finishing, Kitting, Part Marking (Laser & Machine), Ultrasonic Cleaning, Assembly, Testing.
Excalibur Group
Berkeley Square House Berkeley Square Mayfair, London W1J 6BD +44 (0)20 7887 7642 www.excalibur-group.co.uk info@excalibur-group.co.uk
The Excalibur Group is the specialist medical sciences organisation established by Professor Sir Chris Evans. Through its investment arms it manages a range of venture capital, private and public equity investments in the biotech, life sciences and healthcare sectors through its funds and individual investments. Additionally it supports scientific research and development. In addition Excalibur Healthcare Services provides medical and healthcare services, facilities, supplies and expertise to health services across several countries.
Finance Wales Oakleigh House Park Place Cardiff CF10 3DQ +44 (0)800 5874140 www.financewales.co.uk/ earlystage info@financewales.co.uk
42
Finance Wales can invest from £50,000 to £2 million seed or early stage development capital in exciting technology-based businesses and we can invest over a number of rounds. Our technology venture investments team has a wealth of industry expertise and experience as well as a strong network of co-investment partners. We can work with you and potential co-investors to structure an investment that’s right for your business. Finance Wales specialises in technology venture investment and has invested more than £22m in our portfolio of life science companies in the last 5 years. So, if you’re developing and commercialising novel IP, talk to Finance Wales.
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Fulcrum Direct Cardiff Medicentre Heath Park Cardiff CF14 4UJ +44 (0)29 2064 7019 www.fulcrumdirect.co.uk liz@fulcrumdirect.co.uk
Fulcrum’s specialist services facilitate product commercialisation; identify the best routes to market and deliver comprehensive traditional and digital marketing. We specialise in small and SME companies in the biosciences and technology sectors. Our mission is to provide high quality support using professionally qualified and experienced marketing associates to ensure profitable business results for our clients. You will benefit from our independent, cost effective approach to helping you understand your markets, maintain a pipeline of high quality prospects and develop an integrated approach to marketing communications which maximise your sales, whatever channels you choose.
Geldards LLP Geldards LLP is one of the UK’s leading commercial law firms with offices in Cardiff, Derby and Nottingham providing a full range of legal services to clients in the healthcare and life sciences sectors. Dumfries House Dumfries Place Cardiff CF10 3ZF +44 (0)29 2023 8239 www.geldards.com lifesciences@geldards.com
The firm’s dedicated healthcare and life sciences team has a strong track record in dealing with medical technology, knowhow licensing, research and development collaborations, commercial contracts and commercial and intellectual property disputes. Geldards’ clients include start ups, SMEs, universities, hospitals, medical devices companies and large multi-nationals. What others say: “It’s a huge pleasure to work with such professional guys.” Gerwin Bouillon, Global Head of Product Defense, Bayer CropScience AG. “This Cardiff firm continues to impress with the strength of its IP offering. Its solicitors deal with trade mark and patent protection, brand advice and a variety of transactional and licensing matters on behalf of household names.” Chambers & Partners 2011. “Geldards spent time to ensure that they fully understood our business and our requirements. They provided a highly professional and prompt service which completely met our needs.” Clinical Diagnostix Limited
geoFish Medical Marketing Ltd 3 Birch Grove Prestatyn Denbighshire LL199RH +44 (0)7920 250312 www.geofishmedicalmarketing.com geoff@geofishmedicalmarketing.com
Medical marketing consultancy set up by an experienced former Global Medical Affairs Leader in emerging oncology at AstraZeneca with over 20 years experience across clinical development, medical affairs/marketing and communications. Offers a broad range of services centred around development of robust strategy, tactics and communications for drug development and medical marketing activities to deliver high value to patients, clinicians, payers and regulators, based on expertise across a range of therapy areas including oncology (particular expertise in breast, prostate, lung and haematological cancers), anaesthesia, analgesia, intensive care and gastroenterology. Services include: 1) Helping to develop a clear line of sight between emerging drug assets and the market opportunity, through development of validated, future-proof, differentiated target product profiles and target product claims based on a thorough understanding of evolving clinical practice, the competitor environment and customer insight/foresight on future unmet need. 2) Competitive intelligence and analysis. 3) Medical communications activities for emerging and marketed brands including development of science story, publications, key messages, promotional claims, marketing materials and symposia content, and key opinion leader interactions such as advisory boards. geoFish also has an extensive network of commercial experts in the areas of epidemiology, business analysis/insight, forecasting, market research and strategic marketing that can be brought in to support projects, as required.
Grahame Guilford and Company Ty Mawr Pheasant Walk Clos-y-Talcen, Pen-y-Fai Bridgend CF31 4DU +44 (0)1656 667997 guilfordco@btinternet.com
Consultancy, business planning and development services within the life science sector primarily. Services to the higher education sector on commercialisation of research and technology transfer.
43
Grant Thornton UK LLP Grant Thornton is one of the world’s leading organisations of independent assurance, tax and advisory firms. Over 31,000 Grant Thornton people, across 100 countries, are focused on making a difference to clients, colleagues and the communities in which we live and work.
11-13 Penhill Road Cardiff CF11 9UP +44 (0)29 2023 5591 Alistair.G.Wardell@uk.gt.com GX Group
G
R
The Mayfield Usk Monmouthshire NP15 1SY +44 (0)1291 673437 www.gxgroup.com claire.banks@gxgroup.com
U
P
GX Design Engineers is one of the UK’s leading technology and innovation companies. We specialise in the medical and scientific sector helping to develop a wide range of products from hospital beds to urine analysers. We employ a holistic approach to new product design and development utilising years of experience and innovative ideas from our in-house team. Our skills include electronic hardware and software design, industrial and mechanical engineering, as well as specialist areas such as optronics and microfluidics. We are fascinated by the multiple challenges presented by imaginative clients – you know exactly where you want to be and we take immense professional pride in helping you get there. Our engineering excellence and skilful differentiation delivers a competitive product to maintain or grow your market share, whilst setting you apart from your competition. No matter how ambitious your original idea, or how challenging the issues, we have the technical skill, creative talent and sheer commercial know-how to turn it into a reality.
High Performance Computing (HPC Wales) Ty Menai, Ffordd Penlan Parc Menai Business Park Bangor LL57 4HJ +44 (0)1248 675094 www.hpcwales.co.uk/ john.walsh@hpcwales.co.uk
High Performance Computing (HPC) Wales is an innovative collaboration which gives businesses and researchers access to world-class, secure and easy to use high performance computing (HPC) technology. Our supercomputing infrastructure and service is unique in the UK. In partnership with Welsh universities, Government and Fujitsu, we offer the supercomputing power, high level skills training and customised support necessary to help address global challenges, accelerate scientific breakthroughs and answer long-standing questions.
Hugh James Hodge House 114-116 St Mary Street Cardiff CF10 1DY +44 (0)2920 224871 www.hughjames.com lifescience@hughjames.com
Hugh James provides expert corporate legal advice to companies and investors in the life sciences sector. The firm has an established reputation as a market leader having advised major Welsh institutional investors and corporates on numerous life science investments, acquisitions, intellectual property issues and commercial agreements. Our team’s approach is to give commercially focused and practical advice and to understand your business. We can add real value through our comprehensive knowledge of your sector, which we have gained by advising a complete range of companies from start ups and spin-out ventures to major industry leaders and AIM listed international organisations.
IBI Group Morgan Arcade Chambers 33 St. Mary Street Cardiff CF10 1AF +44 (0)29 2044 8900 www.ibigroup.com CD General@ibigroup.com
IBI Group is an award winning practice of architects, planners, landscape architects and laboratory planners. We are committed to providing the best possible support to the scientific community by designing buildings that provide the stimulus and capability for undertaking world leading research, are sustainable and that represent the leading edge in global science design. We recognise global and domestic trends and use this knowledge to influence the shape of future scientific research and manufacturing facilities. We recognise that scientific buildings are highly specialised with very demanding and complex needs. Our team provides a wealth of experience though a network of UK and International studios, giving our clients the confidence that they will always be working with a highly knowledgeable partner with a strong understanding of their values. Our commitment to designing high quality science buildings is driven through the work of our own research and development arm, IBI THiNK. Their research contributes to ongoing learning and thought leadership, the benefits of which are demonstrated by the fact that we have won over 100 awards for design quality, team work and innovation in the UK. Our current research project, 4-Labs-4-Cities is providing an essential insight into the future of research facility design.
inovia
44
30 Broad Street 41st Floor, New York, NY, 1000, USA +44 (0)20 3370 4977 www.inovia.com candida.jaco@inovia.com Twitter: @inoviaIP
inovia provides a foreign filing platform, inovia.com, to simplify and reduce the cost of PCT national stage entry, direct Paris Convention filing, European validation and patent translations. Our client base consists of companies, law firms and universities seeking international patent protection.
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Isca Healthcare Research HIll House Belmont Hill Caerleon NP18 1JX +44 (0)1633 423641 pw@iscahcr.co.uk
Isca Healthcare Research, based near Newport in south Wales, is an established independent provider of expert services in medical device development, pre-clinical testing and evaluation of medical devices, and medical device clinical trials. Our expertise is based on almost 25 years’ experience in the development of medical devices and their clinical validation in the UK, Europe and internationally. We work with clients from the UK, mainland Europe, Scandinavia, USA and Australia. They include multi-national medical device corporations, medical device SMEs and start-ups, the NHS, leading UK universities and teaching hospitals, university technology transfer offices, university spin-outs, IP development companies and venture capital organisations. The services we provide include: medical device development and clinical validation; medical device pre-clinical/clinical trials and project management; clinical trial documentation; MHRA submissions; clinical literature reviews for regulatory submissions; pre-audit review of clinical regulatory submission documentation; and medical and study report writing.
Leadin Institute of Life Science Swansea University Singleton Park Swansea SA2 8PP +44 (0)7982 816253 www.leadin.co.uk harri.mansikkamaki@leadin.co.uk
Leadin is a user experience and service design & implementation agency. We work within demanding environments, complex systems and new technologies. We are experienced to create solutions for people having special needs like visually impaired, diabetics, people with cognitive, motoric and development disabilities as well as children and elderly. Leadin always puts people - the real users of the system - into the focal point by studying them, creating the solutions for them and verifying the outcomes with them. Digital interfaces and mobility are in-built into the DNA of Leadin personnel, who are willing and capable to create new solutions, improve existing systems and push promising business ideas into market by providing user understanding, interaction and visual design, software development and business model coaching.
Majakel Medical 10, The Meadows Marshfield Cardiff CF3 2AY +44 (0)1633 680979 www.majakel.co.uk steven.patterson@majakel.co.uk
Majakel Medical provides practical and professional consulting and support services to help manufacturing and development companies compete successfully in the healthcare sector. With many years of experience developing new medical devices, installing quality systems or improving process we pride ourselves on practical solutions to user needs.
MEDDEV QA 5 Hillside Drive Cowbridge Vale of Glamorgan CF71 7EA +44 (0)1446 774948 +44 (0)7714 288232 medicaldevices@aol.com
Product development planning; initial quality and regulatory gap assessments and pre-assessment audits; part-time quality management services; quality systems and CAPA training; implementation and upgrading of quality systems for ISO 9001, ISO 13485, FDA 21, CFR 820 and the EU medical device directives; device classification queries; preparation of technical files and design dossiers for CE marking; liaison with regulatory bodies; field safety corrective action management, EC vigilance reporting and FDA MDR reporting; liaison with notified bodies and other regulatory bodies; internal auditing and vendor quality system auditing; ongoing QA/RA support; EU authorized representative services for non-EU based operations.
Medical Connections Suite 10, Henley House Queensway Fforestfach Swansea SA5 4DJ +44 (0)1792 390209 www.medicalconnections.co.uk Dave@medicalconnections.co.uk
Medical Connections Ltd is a small, innovative medical imaging software and consultancy company, created with the aim of making medical image and record integration simpler, faster, cheaper and more reliable. Established and managed by Dr David Harvey, a radiologist, as a result, both requirements and development are seen from the enduser’s perspective, providing solutions tailored to the real clinical environment. The main toolkit products are DicomObjects, for the development of DICOM conformant applications for medical imaging, and XdsObjects, for other clinical records. 60 day trial versions are available.
Medical Connections Ltd also provides consultancy services in the field of medical image integration, and can advise suppliers, integrators, purchasers and government agencies on how best to achieve their goals in this area. This can include advice on choice of communication methods, conformance testing and even dispute resolution. In addition, we can provide customised software solutions for specific DICOM needs, such as routing, on-the-fly modification etc.
45
Nine Health CIC ILS 1 Swansea University Singleton Park Swansea SA2 8PP +44 (0)8454673790 and +44 (0)1792 606224 www.ninecic.org.uk elaine.taylor-whilde@ninecic.org.uk
We are a not for profit community interest company set up for the benefit of patients and public from the NHS. We drive research, uptake and the development of clinical technology specialising in data processing, research and collaborative partnerships. We support a number of innovative organisations from proof of concept through to market entry and are always willing to hear from innovators and entrepreneurs wanting to work with the health and social care field or those with good ideas. We work throughout the EU, and UK and are moving into Asia’s markets in the next month.
OSP Healthcare Ashbourne House 33 Bridge Street Chepstow Monmouthshire NP16 5GA +44 (0)1291 636308 www.OSPHealthcare.com Richard@OSPHealthcare.com
OSP Healthcare helps ambitious health and life sciences companies to launch and promote their products and services. We specialise in producing innovative communications which bring science, creativity and faultless execution together to transform the understanding and behaviour of your audience. Proven expertise in compelling communications to motivate and educate — from strategy to execution, across the broad range of external and internal marketing, design, branding, event, exhibition, meetings, digital and online services. EXPERIENCED 20 years’ know-how across a broad range of therapy areas and medical devices. STRATEGIC Joined up thinking from concept to execution. CREATIVE Inspired ideas, beautifully executed. AWARD-WINNING Effective communication to shout about — proof of RoI and creativity. MULTI-NATIONAL 80% of work is outside the UK — we have the expertise to help you compete in a global market.
Pharmallaney Chestnuts Cross Ash Abergavenny NP7 8PB www.pharmallaney.com g.mollaney@btinternet.com
Pharmallaney Ltd was established in 2010 based on a foundation of over 25 years’ experience within the pharmaceutical industry and supporting medical devices. This experience also includes involvement with clinical trials, commercial and distribution practices within small to large companies. Pharmallaney Ltd aim is to provide pragmatic, effective and efficient compliance and strategic management. Core activities include Qualified Person certification, training, audit support and quality system improvement.
Sony UK Technology Centre
Pencoed Technology Park Bridgend CF35 5HZ +44 (0)1656 860666 www.sonypencoed.co.uk UKTEC_Biz_enquiries@eu.sony.com
We are the only manufacturer of Professional and Broadcast Camera Systems for Sony Corporation with a worldwide customer base located outside of Japan. We also act as a Contract Electronics Manufacturer of professional, industrial and consumer electronic devices including the world famous Raspberry Pi credit card sized computer, offering the complete business solution to various market leading companies. Our facilities include a state-of-the-art SMT facility, Poke Yoke cell assembly, test jig design capability, award winning service and customer call centre and SCM services and DFM engineering support.
Teamworks Teamworks provides a range of brand-focused design, marketing and publishing services to life science organisations. 7 Schooner Way Atlantic Wharf Cardiff CF10 4DZ +44 (0)29 2047 3455 www.teamworksdesign.com studio@teamworksdesign.com
46
With over 28 years experience, our clients include many of the sector’s most recognised public and private sector names. They trust in our ability to deliver what they need when they need it, time after time. Our in-house team of creatives and digital developers allow us to deliver comprehensive solutions from concept through to completion. Specialist knowledge and understanding of the sector allows us to focus on providing solutions that are both striking and strategic. Typical projects include: branding and rebranding website design and build (including mobile) promotional literature copywriting and content generation editorial and design of publications conference and exhibition design and branding
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Teamwork Technology Services Institute of Life Science Singleton Park Swansea SA2 8PP +44 (0)8000 803003 www.teamworkict.com info@teamworkict.com Twitter: @teamworkict1
Teamwork Technology Services Limited is an established independent ICT consultancy and managed services company based in South Wales but with its client base spanning the UK. The company is active in the biotechnology, pharmaceutical and healthcare sectors and has extensive experience working with SMEs across a wide range of sectors advising them of the most appropriate ICT solutions for their business. As well as providing independent consultancy services to growing SMEs, Teamwork is a principal provider delivering subsidised ICT consultancy services to eligible Welsh SMEs through the Welsh Government e-Business Support programme. Teamwork is currently developing e-security and e-health areas of the business.
Triteq The Innovation Centre Station Road Hungerford Berkshire RG17 0DY +44 (0)1488 684554 www.triteq.com angela.hobbs@triteq.com Twitter: @triteq
Triteq is a product design and development company We use a combination of creativity, collaboration, experience and knowledge to deliver successful products. From concept to prototype and every stage inbetween. Combining knowledge and experience to produce excellent results .We work with entrepreneurs, SME’s, academic institutions and corporations. We invest in understanding behavioural change to ensure that your product provides what your target audience needs to day and tomorrow. Talk to us today. Specialisms: Design strategy, research, software development, electronic engineering, user experience design, validation & verification, prototype, manufacturing.
Tybio The Forge Hendre Pencoed Bridgend CF35 6RA +44 (0)791 756 8954 mollypj@tybio.co.uk
Partnering clients to achieve their goals is Tybio’s specialist skill. Past projects have included: integrating acquired businesses to managing business transitions and productivity improvements mentoring key management personnel to defining product development processes implementing cost reduction strategies to the timely launch of new products Tybio offer a bespoke service that combines scientific understanding with proven commercial acumen and a depth of board level experience within the life science and food industry sectors.
UPG Cwm Cynon Industrial Estate North Plateau Mountain Ash RCT CF45 4ER +44 (0)1443 471200 www.upgintl.com/manufacturing nparsons@upgintl.com
UPG is an innovative global provider of product development and manufacturing solutions servicing the medical market with tooling design and construction, custom injection moulded plastic components, semi-finished subassemblies to multifaceted fully finished final products. UPG manufactures components and assemblies for an array of medical markets and products, Class 1 and Class 2 medical devices. Highly cosmetic and fully functional parts. This includes minimally invasive surgical devices; respiratory, anaesthesia and catheter devices; infusion, diagnostic instruments and devices; and patient monitoring systems. UPG global expertise and processes are tailored to meet the stringent demands for today’s healthcare products.
UK Healthgateway 23 Cae Rex Llanblethian Vale of Glamorgan CF71 7JS +44 (0)7900 570172 www.ukhealthgateway.com jon@ukhealthgateway.com
UK Healthgateway is the specialist UK health market entry expert. We offer: Distributor search Regulatory certification (CE all grades) Market research Clinical product assessment & trials Commercial planning Clinical PR and product advocacy Legal and financial planning Our network of expert Associates are the best in the business and our clients benefit from an unrivalled contacts network and NHS process understanding. Whether your product is equipment, device, consumable or pharmaceutical, we will make your market entry successful.
47
Urquhart-Dykes & Lord LLP Churchill House Churchill Way Cardiff CF10 2HH +44 (0)29 2064 2150 www.udl.co.uk cardiff@udl.co.uk Twitter: @UrquhartDykes
In an increasingly competitive world and global market, the protection of intellectual property is vital to commercial success. Particularly in the medical sector where many of the major players are based in the US or Japan, Welsh innovators need to keep ahead of the game. UDL is one of the largest firms of patent and trade mark attorneys in Wales. Through its many years of experience working in the medical field, UDL has the expertise to advise you on all aspects of patents, trade marks and designs. To find out how we can help you protect some of your most valuable assets, visit our website or contact Tom Baker or Annabel Hanratty.
Waterside Consulting Waterside Consulting Ty Blaenant Ddu, Felindre Swansea SA5 7ND +44 (0)1792 793866 www.waterside-consulting.co.uk sueh@waterside-consulting.co.uk
At Waterside we are highly experienced in powerfully creating space for leaders and senior teams to step back and release fresh thinking that is vital for their next step forward. Clients across life sciences and healthcare particularly value the breadth of strategic insight that Waterside brings; the capacity to ask incisive questions that break open thinking; and the ability to quickly create an environment for conversations that matter. They tell us that the outcome is hugely creative and beyond their expectations. If you are exploring where you need to be in the bigger picture, working across boundaries or pursuing innovation through collaboration then we would be delighted to hear from you.
Welsh Government - Life Sciences Team Llys-y-Draig Penllergaer Business Park Penllergaer Swansea SA4 9NX +44 (0)3000 603000 www.business.wales.gov.uk lifesciences@wales.gsi.gov.uk
The Welsh Government is committed to making Wales the best possible environment for Life Sciences innovation and business growth. The focus of the Welsh Government’s Life Sciences Sector Team is on business growth and commercial success. We have access to a range of funding mechanisms and related programmes and infrastructure to support the location, development and growth of businesses in Wales. We also have joined up routes across Government Departments to support academia and the NHS to pursue and share research excellence to benefit the economy and the people of Wales. This combined with the £100 million Life Sciences Investment Fund, the largest dedicated investment fund for any sector in Wales, the launch in July 2014 of Life Sciences Hub Wales in the heart of Cardiff Bay has placed Wales on the world stage for Life Sciences innovation and development. As a location, Wales provides a dynamic, innovative culture for pursuing discoveries, new product development, clinical trials, manufacturing and taking products to market.
Wentwood Medical The Manse Tabernacle Lane Llanvaches Cadidcot NP26 3BL +44 (0)7748 637400 www.wentwoodmedical.com scottforde@wentwoodmedical.com
Wentwood Medical provides sales and marketing expertise to the healthcare, biotechnology and pharmaceutical sectors in the UK and Europe. Our Services Include: Start up Company Sales, Marketing and Business Operational Brand Management Services Strategic Brand Planning Services Strategic Brand Planning Services Warehousing, Storage, Distribution Services Wentwood Productions provides a wide range of communication and promotional services to companies and organisations in the UK, Europe and around the world. Our Services Include: Integrated Marketing Campaigns Concept Development for Products and Services Video and Photography Design and Print Electronic Media Writing Live Events
48
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Wipak UK Ltd Unit 3 Buttington Business Park Welshpool Powys SY21 8SL +44 (0)1938 555255 www.wipak.com marcus.kennedy@wipak.com
WIPAK is an innovative, leading global supplier of sterile barrier systems and high-end packaging solutions for medical device manufacturers and the pharmaceutical industry. WIPAK’s multilayer films and medical papers are designed for packing single-use medical devices and health care products. Interactive Packaging – featuring either augmented reality (AR) or watermark technologies - and antimicrobial treated films, papers and pouches are amongst the latest developments now being delivered by WIPAK. Wipak’s health care packaging and products are developed and designed to ensure optimal reliability of use in hospitals and other health care institutions. Our STERIKING® products are manufactured in Clean-Room conditions and surpass the requirements set out in international standards and norms. We care that you pack safely!
Withers & Rogers LLP 1 Redcliff Street Bristol BS1 6NP +44 (0)1179 253030 www.withersrogers.com admin@withersrogers.com
Withers & Rogers LLP is one of the leading intellectual property law firms in the UK and Europe and active with clients in the Welsh medical sciences sector. We also have a permanent space at the Life Sciences Hub in Cardiff, as part of Scinapse, a collaboration with the law firm Geldards and accountants Broomfield & Alexander, which aims to provide professional services support for early stage and growing businesses in the healthcare and life sciences sector in Wales. We specialise in the protection and enforcement of intellectual property rights including patent protection for inventions, trademark registration for brands and design rights, (registered and unregistered) for products. We act in patent and design right infringement proceedings. With more than 70 experts with specialist experience in many industry sectors, we enjoy working closely with our clients so we can advise them on the best intellectual property strategy to meet their needs. Our Life Sciences & Chemistry principal practice group is one of the largest in Europe, with a depth of expertise and experience in the chemical, biochemical and pharmaceutical industries, as well as in academic research. Our highly skilled Medical Device and Medical Imaging specialist practice groups are supported by attorneys from across our principal practice groups.
Wynne-Jones IP Temple Court 13a Cathedral Road Cardiff CF11 9HA +44 (0)29 2078 6535 www.wynne-jones.com/ michell.ward@wynne-jones.com
Wynne-Jones IP is a long established firm of Chartered and European Patent and Trade Mark Attorneys, based in Cardiff and Cheltenham, and more recently Telford and Wrexham. We act for a large number of clients locally, nationally and internationally, including private individuals, multi-nationals, large technology-based companies, SME’s and universities. We specialise in intellectual property (IP) services, including a full spectrum of patent services in engineering, life sciences, healthcare, medical devices, medical detection techniques, biotechnology, chemistry and nanotechnology. IP plays a vital role in the modern business environment. Whether it be protecting and realising the value of inventions, proprietary technology, brands or original designs, getting the right advice is key. We provide a quality service and our goal and focus is always on the business needs and objectives of the client. Our attorneys have extensive experience in Patents, Trade Marks, Designs, all aspects of IP licensing and enforcement, and IP audits.
xénos, the Wales Business Angels Network Oakleigh House Park Place Cardiff CF10 3DQ +44 (0)29 2033 8144 www.xenos.co.uk/ Lisa.Mitchard@xenos.co.uk
xénos, The Wales Business Angel Network brokers deals between business angels (high net-worth private individuals) and businesses and/or individuals seeking investment. The network is part of the Finance Wales Group and has facilitated over £22 million of private investment into well over 200 Wales-based businesses since its formation in 1997. xénos investors fund all stages of development from seed-corn and early stage, through to expansion, acquisition and turnaround. The network has more than 100 registered investors seeking investment-ready opportunities.
Zenith Print Group Gellihirion Industrial Estate Treforest Pontypridd CF37 5SX +44 (0)1443 848212 or 07900214089 www.zenithprintgroup.com lyndon@zenpak.co.uk
Zenith Print Group offers an expansive range of Print, Packaging and Graphic capabilities. The company produces many kinds of print & packaging including, company brochures, leaflets, clinical trials packaging, diagnostic kits, blister cards, retail ready product packaging and large format digital graphics including exhibitions. Our sites in South Wales, London, Bristol and Liverpool service pharmaceutical and healthcare clients throughout the UK.
49
Academic Academic Health Science Partnership for South East Wales UHW Main Building Heath Park Cardiff CF14 4XW +44 (0)29 2074 3146 www.medicine.cf.ac.uk/sewahsp/ SEWAHSPAdmin@cardiff.ac.uk
The Academic Health Science Partnership for South East Wales is an alliance with a mission to cooperate and collaborate strategically and operationally, to integrate high quality research and education and enhance the region’s outputs in developing and applying improvements, innovations and health technologies to benefit the health and wealth of the population of Wales. The Academic Health Science Partnership for South East Wales was formed by the Higher Education Institutions and NHS organisations in South East Wales to reduce fragmentation in R&D and accelerate health improvement in line with Government policies. It will work closely with industry and funders, and bring together researchers, managers, practitioners, patient groups, planners and policy makers to achieve the mission.
ASTUTE ASTUTE - Project Office Digital Technium College of Engineering Swansea University Swansea SA2 8PP +44 (0)1792 606378 www.astutewales.com info@astutewales.com Twitter : @AstuteWales
ASTUTE (Advanced Sustainable Manufacturing Technologies) is a £27m five year project part funded by the European Regional Development Fund through the Welsh Government, which aims to boost the competitiveness of the Welsh economy through supporting manufacturers and their supply chains within the Welsh Convergence Area. The project provides Welsh industry with ready access to a unique combination of technical and business expertise and specialist facilities available across eight Welsh universities, providing assistance with key industry challenges to facilitate industrial growth and long term sustainability. ASTUTE can assist your business by providing specialist advice and technical assistance through collaborative R&D projects in adopting new technologies, or improving your business processes. ASTUTE’s expertise of direct relevance to bioscience businesses includes: Advanced Technologies: Molecular Biology, Process Chemistry, Micromanufacturing, Micro/Nano-metrology Microcontrollers, Master/Toolmaking, Prototyping & Replication Product & Design & Innovation: Digital Design & Manufacturing, Prototype & Process Design Operations Management: Clean Room Manufacturing, Lean & Sustainable Manufacturing, Supply Chain Logistics
Bangor University - Research and Enterprise Office The Management Centre College Road Bangor Gwynedd LL57 2DG +44 (0)1248 388 847 gmayhead@bangor.ac.uk www.bangor.ac.uk
The Research and Enterprise Office supports two key components of the University’s mission; delivering its aspiration to be a research led institution with an international reputation and contributing to the economic well being of Wales and the wider community. The Research and Enterprise Office supports the delivery of the University’s Research, Knowledge Exchange and Innovation activities and provides a central contact point for businesses and other external organisations wishing to access expertise and services at Bangor.
PDR (National Centre for Product Design and Development) 200 Western Avenue Cardiff CF5 2YB +44 (0)29 2041 6725 www.pdronline.co.uk jwevans@pdronline.co.uk
PDR is a world renowned design and innovation consultancy and research centre. Our work encompasses the full range of new product development support from original research and human factors through to design, prototyping, trial and New Product Introduction (NPI). PDR has significant and proven experience in medical device development in all classifications from simple disability devices and medical furniture through to complex diagnostic tools and drug delivery systems. Device development at PDR is undertaken through a proven design methodology that employs the latest design and manufacturing analysis tools and technologies to produce robust, compliant and commercially successful solutions. A deep understanding of the user and clinical needs is key and acts as the foundation to a reliable and proven product development and risk reduction process. Usability and human factors. Specification and feasibility analysis. Conceptual design and visualisation. Mechanical engineering and detail design for manufacture. Broad manufacturing discipline experience from low to high volume and UK to offshore. Regulatory compliance support and technical file construction. Design, process and user FMEA’s. In house FEA (including non linear dynamic analysis). In house high fidelity rapid prototyping. In house mouldflow and tooling support. In house low volume rapid manufacturing technology.
50
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Cardiff University Central Biotechnology Services Central Biotechnology Services is a BS EN ISO 9001:2008 certified Technology Facility offering postgenomic and cell analysis/imaging platforms and expertise to Cardiff University researchers and external organisations.
Henry Wellcome Building Cardiff University School of Medicine Heath Park Cardiff CF14 4XN +44 (0)29 2068 7004 www.medicine.cf.ac.uk/cbs/ CBSAdmin@Cardiff.ac.uk
Our technology platforms include: Genomics (Affymetrix and Illumina microarray platforms, DNA sequencing, quantitative PCR), Proteomics (liquid chromatography, tandem mass spectrometry, BiaCore), Flow Cytometry and Cell Sorting, Confocal Imaging, Electron Microscopy and High Throughput Biomarker Assay Platforms. External clients can access our state-ofthe-art technology platforms on a contract basis and we have had many successful interactions with start-up companies, SMEs and large multinational organisations. Beyond our standard services, we offer extended scientific support from our team technologists and also potentially offer, on a case-by-case basis, opportunities for hosting companies and providing laboratory facilities.
Cardiff University - Innovation and Engagement Institute of Translation, Innovation, Methodology and Engagement (TIME) Cardiff University School of Medicine University Hospital of Wales Main Building, 2nd Floor Cardiff CF14 4XN +44 (0)29 2074 6735 www.medicine.cf.ac.uk/translationinnovation-engagement/ innovation-engagement/ hatchs@cf.ac.uk
Innovation and Engagement is an integrated part of Cardiff University’s core mission – it delivers the impact of our Research and Education excellence. In the School of Medicine it is core to our mission and ethos. The Innovation and engagement team are located in the cross-cutting Institute of Translation, Innovation, Methodology and Engagement (TIME). From here the team realise opportunities that will fulfil the University’s vision to be one of the world’s leading universities creating global impact through our academic excellence by: Excellence in effective translation and dissemination of our research Delivery of highly skilled people to the labour market, and Effective engagement with our communities
Cardiff University - Research and Innovation Services 7th Floor, 30-36 Newport Road Cardiff CF24 0DE +44 (0)29 2087 5834 www.cf.ac.uk/for/business business@cardiff.ac.uk
Cardiff University has an ‘Open for Business’ policy which aims to bring academia and business together through collaborations ranging from a few hours of consultancy or contract research to multi-million pound consortium grants involving numerous industrial and academic partners. Research and Innovation Services is the business facing arm of the University’s central administration and supports business by acting as a single point for initial contact and intermediary to connect industry with those academics having the knowledge and expertise to help with their needs. Within the department, the Business Development Team facilitates first meetings, the development of collaborative projects, helps gain funding and supports projects to completion. Similarly, within Research and Innovation Services, the Technology Transfer Team exists to identify and develop novel technologies generated out of the University’s world-leading research activities. These technologies are prepared for their transfer, application and exploitation outside the academic environment, often through patenting, licensing and new company formation. Here’s some of what we can offer: Innovation Network, Consultancy and Research, Knowledge Transfer Partnerships, Professional Development, Technology licensing, Spin-out company establishment , Investment opportunities
Cardiff University - Wales Research and Diagnostic PETIC Room 694 Ground Floor ‘C’ Block Cardiff University Heath Park Cardiff CF14 4XN +44 (0)29 2074 3070 www.medicine.cf.ac.uklen/petic petic@cardiff.ac.uk
PETIC is a cyclotron-based production facility which provides radiopharmaceuticals for both diagnostic and research utilising both clinical and pre-clinical PETCT scanners. PETIC provides research opportunities across the Schools of Medicine, Bioscience, Chemistry, Pharmacy, Psychology and Optometry, in addition to All Wales Research Networks. The provision of the pre-clinical PET facility will be particularly attractive to the pharmaceutical industry. PETIC also offers a clinical scanning facility able to provide scans with FDG (Oncology, Neurology), F Choline (Prostate Cancer), NaF (Bone Scan), Florbetapir (Amyloid Plaque in Alzheimer’s) and F DOPA (Dopamine system and Parkinson’s Disease). PETIC has plans to develop a neurological research focus and introduce scanning of GABA receptors, Glutamate receptors, microglial activation and Tau protein. In addition, PETIC offers novel radioisotopes such as Zirconium 89 and Yttrium 86 with which PETIC is able to label and image monoclonal antibodies.
51
Cardiff University - Wales Gene Park
ie Alcock, Project Manager: e.alcock@mediwales.com Heath Park
Cardiff CF14 4XN ss Coughlan-Allen, +44 (0)29 2074 6940 mmunicationswww.walesgenepark.cardiff.ac.uk Manager: s.coughlan-allen@mediwales.com burgessam@cf.ac.uk
The Wales Gene Park supports medical genetic research and its translation to advances in healthcare, delivers education and facilitates engagement in genetic issues within the NHS and with the wider public. Through its work it seeks to ensure that the many opportunities presented by new genetic knowledge and technologies are capitalised on in Wales.
Swansea University Swansea University has enjoyed a period of tremendous growth and aims to be a research intensive UK top-30 UK University by 2017 and within 2% of the top Universities in the World. An ambitious Campus Development Programme is well underway - one of the largest knowledge economy projects in the UK and within the top 5 in Europe. It involves the creation of the Bay Campus, a brand new £450 million development which will be home to Colleges of Engineering and Management, together with the transformation of our existing Singleton Park Campus with a focus on Life Sciences and Cultural Arts. This expansion will allow the University to create space to help foster increased collaboration with industry from small to medium sized enterprises to large multinationals. By co-locating academic and industry research such as in the Institute of Life Sciences and the new Bay Campus, the University will contribute to the knowledge economy by acting as a catalyst for the growth of high-technology clusters in the region by providing access to cutting-edge research, state-of-the-art equipment and some of the brightest students to help commercialise ideas. GOVERNMENT
At Swansea University we can…. Help solve a technical or business challenge via focused Research and Development support Provide training opportunities for you and your workforce Help you recruit highly qualified graduates and engage with our students on a bespoke research project or placement Advise on intellectual property, patents, licensing technology and setting up spin out companies
Swansea University - Centre for NanoHealth Swansea University ILS Building 2, Singleton Park, Swansea, SA2 8PP +44 (0)1792 606471 www.swansea.ac.uk/nanohealth nanohealth@swansea.ac.uk
The Centre for NanoHealth (CNH) is a unique open access interdisciplinary research centre based on the application of Nanotechnology leading innovations in Healthcare. Established in 2009, the Centre for NanoHealth at Swansea University combines nanotechnology with medical science to provide opportunities to develop innovative solutions to the world’s challenge of detecting the onset of diseases at the earliest stage. Novel devices, processes and sensors can be designed, manufactured, functionalised, tested and evaluated for point of care, near–patient and in vivo applications. In recent years, nanotechnology has been closely linked with applications in almost every industry. The application of nanotechnology in healthcare offers incredible opportunities and is an area where significant growth is now beginning to emerge. The centre offers a fully integrated nanotechnology and biomedical Research & Development environment with expertise in:Biology and advanced cell imaging – The centre includes a category 2 biomedical suite of laboratories offering cell and molecular biology capabilities, including confocal microscopy, and high-throughput/high-content analytical systems (Amnis Imagestream & GE In Cell); microbiology, informatics & modelling, regenerative medicine, tissue engineering and nano(geno)toxicology. Characterisation with equipment capable of electrical, physical & chemical analysis. Micro-Nano fabrication- from sensors and devices, microfluidics & MEMS to printing & coatings. Incorporated is a fully equipped nano-fabrication and characterisation class 1000/100 cleanroom for silicon and non-silicon based developments, a class 1000 bioclean room for tissue engineering and device functionalization, NMR, rheology and biomolecule printing. Collaboration is strategically imbedded within the academic and business ethos of the centre. The centre is committed to supporting SMEs to multinationals with an interest in nanotechnology and healthcare; through access to expertise, state-of-the-art equipment and facilities and to form strategic partnerships to develop and drive forward the centre’s research and commercialisation vision.
52
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Swansea University - Department of Computer Science Swansea University Singleton Park Swansea SA2 8PP +44 (0)1792 603026 j.c.doyle@swansea.ac.uk
Improving medical technology safety through the development of safer technologies; providing an independent view during design and development of products, assessing safety by combining methodical research with thorough testing that considers real-life circumstances. Areas of expertise: human-computer interaction, user-experience and usercentred design. Target sectors: health boards; industry (medical device manufacturers, software developers, designers); regulators; charities.
Swansea University – College of Medicine and Institute of Life Science Grove Building Singleton Park Swansea SA2 8PP Enterprise and Innovation: +44 (0)1792 513718 www.swansea.ac.uk/ils/ ilsinnovation@swansea.ac.uk
The Institute of Life Science (ILS) Swansea University’s College of Medicine is dedicated to delivering education, research and innovation in partnership with industry and the NHS. It aims to deliver a curriculum containing research, IP generation, knowledge transfer and innovation and to embed these skills into practice to make a direct and meaningful impact on people and patients. It is home to Wales’ only fast-track graduate entry programme for training doctors, as well as undergraduate genetics and biochemistry programmes and a growing range of postgraduate opportunities. The research and innovation arm of the College of Medicine, the Institute of Life Science (ILS), is Wales’ premier purposebuilt medical research and business incubation facility. A partnership between Swansea University, Welsh Government, the NHS and industry. The ILS vision is to advance medical science through multi- and interdisciplinary research and innovation for the benefit of human health and the economy. Research is grouped into four themes – biomarker and gene discovery; microbes and immunity; medical devices; and patient and population health and informatics – all of which are supported by platforms including informatics, data science, molecular medicine, nanohealth and a joint clinical research facility with the NHS. Cross cutting these are clinical interfaces due to the partnership with the NHS – Abertawe Bro Morgannwg University Health Board in particular. Unique facilities at the ILS include the EPSRC National Mass Spectrometry Facility, the MRC Centre of Excellence in eHealth Research (CIPHER), the Health Informatics Research Laboratories, the NHS Wales Research Informatics Laboratories and extensive high performance computing capabilities through IBM and HPC Wales. It is also home to the Joint Clinical Research Facility (JCRF), which boasts a bedded clinical trials unit and an imaging suite fitted with CT and MRI scanners. 2014 is the College of Medicine’s 10th anniversary. Find out more in its commemorative book, History in the Making, at www.scribd.com/SwanseaMedicine
Swansea University - eHealth Industries Innovation (ehi2) Centre Second Floor Institute of Life Science (Building 2) Swansea University Singleton Park Swansea SA2 8PP +44 (0)1792 295627 www.ehi2.swansea.ac.uk e.l.hughes@swansea.ac.uk
The eHealth Industries Innovation (ehi2) Centre is a business-facing centre for the ehealth industries, supporting the development of the ehealth sector in Wales. It offers companies access to healthcare facilities and technologies and informatics expertise. The Centre is home to the Welsh Node of the National Virtual Incubator (NVI) which provides free networking, events and a mentor support programme for life science & ICT start ups and SMEs. In 2015 the team at ehi2 will be hosting the Digital Health Assembly: ‘Open Innovation’ Conference in the SWALEC Stadium, Cardiff. The conference, which takes place from the 10-12 February 2015, welcomes digital health professionals from around the world to unite in a common goal – to accelerate developments in ehealth through Open Innovation.
Swansea University - College of Human and Health Sciences Swansea University Swansea, SA2 8PP +44 (0) 1792 602785 www.swansea.ac.uk/ humanandhealthsciences/ business/ s.herrieven@swansea.ac.uk
The College of Human and Health Sciences draws together the disciplines of health, nursing, midwifery, social care, social policy and psychology and is the largest provider of health care education in Wales, providing an exciting and dynamic environment in which to study and further an academic or professional career. With 20 professorial staff, the College’s mission is to conduct high quality international research that meets the needs of the people of south-west Wales and beyond. The College offers undergraduate degrees, postgraduate certificates, postgraduate diplomas, stand-alone modules, Masters, MPhil, PhD and DProf programmes. The College’s Business, Consultancy and Development Services have been set up to offer affordable, reliable services to public and private sector businesses and organisations across Wales, and further afield. With 169 academic staff in the College and 13 specialist research centres, our expertise covers many subjects, including ageing, health, social care, social policy and psychology, as well as business and organisational development. If you want to develop a product, service or operational process or would like to up-skill your staff with bespoke training courses, find someone to delivery mandatory training, research an idea alongside internationally recognised experts, or use state-of-the-art health care or conference facilities then please contact us to discuss your needs.
53
University of South Wales - Faculty of Life Sciences and Education Lower Glyntaff Campus Pontypridd Wales CF37 1DL +44 (0)1443 483100 www.southwales.ac.uk carl.peters@southwales.ac.uk
The University of South Wales is one of the largest universities in the UK. We have a strong tradition of health science education at all levels, from undergraduate training to postgraduate study and research. With a focus on the workplace and preparation for practice, we provide students with the attributes, skills and knowledge to deliver a high standard of care in contemporary healthcare settings. The University also offers short courses for students and health professionals to develop their skills. The flexibility of these courses allows professionals to continue their development around the demands of work, plus many courses are delivered entirely online. Researchers in the faculty provide solutions to real-life problems. We have a holistic approach that brings together researchers from traditional health and care sciences backgrounds with basic science and medical researchers, and creates links with health economics, social policy and psychology
West of England Academic Health Science Network South Plaza, Marlborough Street, Bristol BS1 3NX 0117 900 2157 et@weahsn.net www.weahsn.net
The West of England Academic Health Science Network is a vibrant and diverse network of partners (providers of NHS care working with universities, industry, NHS commissioners and a wide range of other organisations) working to put innovation at the heart of healthcare, to improve patient outcomes and contribute to wealth creation. We are one of 15 Academic Health Science Networks and our four key objectives are to; focus on needs of patients, accelerate the adoption of innovation into practice to improve clinical outcomes and patient experience, build a culture of partnership and collaboration and make a meaningful contribution to the West of England and UK economy. We are developing new approaches to linking universities and industry sector with the NHS to adopt new solutions for the benefit of our patients and also to harness the potential of the NHS to deliver economic growth. We facilitate engagement and provide access to partners and collaborators. In addition, we provide advice on available resources including funding opportunities to assist the spread of innovative solutions.
54
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Charities ASH Wales ASH Wales is the only voluntary organisation in Wales with the sole task of tackling the ill health caused by tobacco use. We have been working in Wales since 1976, and since 2007 as a separately devolved charity. Our activity is increasingly with children and young people as Wales has some of the highest numbers of young smokers. 8 Museum Place Cardiff CF10 3BG +44 (0)29 2064 1101 www.ashwales.org.uk john@ashwales.org.uk Cerebra Cerebra is a charity helping brain injured children. It set up its Innovation Centre in conjunction with the Swansea Metropolitan University to provide a research, design and manufacturing service to design and build specialist equipment and adaptations that are not already available to buy. The Innovation Centre consists of a small team of designers who are able to respond to requests to build bespoke and small production runs of products to help children with neurological conditions.
2nd Floor Offices Lyric Building, King Street Caramarthen SA31 1BD +44 (0)1792 483688 www.cerebra.org.uk rossh@cerebra.org.uk
We have expertise in the areas of electronics, design and engineering. We also work with a range of industry partners and other charities in the development of products.
Tenovus At Tenovus our aims are simple: to help prevent, treat and find a cure for cancer. In doing that we offer support, advice and treatment for cancer patients, information on cancer prevention and funding for research to improve the outcomes for people with cancer. We do this where it is needed most – right at the heart of the community. Gleider House Ty Glas Road Cardiff CF14 5BD +44 (0)29 2076 8850 www.tenovus.org.uk post@tenovus.org.uk
Our vision: Tenovus wants a future where: Fewer people get cancer Everyone with cancer will have equal access to excellent treatment and support Our mission: We will work in partnership to deliver innovative research-led cancer prevention, treatment and support in the community to people with the greatest need, initially in Wales. Our aims: To deliver this vision, we have agreed a set of 4 strategic aims for the organisation for the next five years. They are: Aim 1 To provide treatment to cancer patients closer to home Aim 2 To improve equity of access to cancer services Aim 3 To deliver unique support services to cancer patients and their families Aim 4 To conduct and fund research to improve cancer outcomes and experience
Cancer Research Wales At Cancer Research Wales our overriding aim is to reduce the impact of cancer on the people of Wales through supporting world class cancer research and education. We are proud to guarantee that all money raised is spent in Wales. Velindre Hospital, Whitchurch, Cardiff, CF14 2TL +44 (0)29 2031 6976 www.cancerresearchwales.co.uk @cancer_wales
We sponsor pioneering research projects carried out by internationally renowned scientists and PhD students’ at universities and hospitals across the Principality. We also fund Wales’ only specialist cancer library. The Cancer Research Wales research portfolio includes a range of projects that focus on many site specific cancers, these include amongst others, cancers of the prostate, colon, cervix, kidney, breast, head and neck and blood (leukaemia). We have always been keen to promote and encourage the rapid transition of science from the laboratory to the bedside. We are only able to fund such pioneering cancer research projects because of the wonderful support which we receive from the public.
55
2013 MediWales Innovation Awards Winners The MediWales Innovation Awards 2013 celebrated the fantastic achievements of life science companies and individuals from the NHS in Wales. A priority sector in a tough economy, Welsh industry’s innovative partnerships with the NHS and academic institutions significantly contribute to the health and wealth of Wales. The 320-guest Awards Dinner, sponsored by National Institute for Social Care and Health Research (NISCHR), Abel & Imray, Geldards LLP, GX Group, and Elite Electronic Systems, was held at Cardiff’s National Museum on Tuesday 10th December to an audience of senior industry, NHS and government representatives. Innovation within the NHS Award NHS Partnership with Welsh Industry Award NHS Judges’ Award Innovation Award Start-up Award Outstanding Achievement Award Partnership with the NHS/Academia Award Judges Award Export Achievement Award
56
Velindre NHS Trust Medical Physics Department Abertawe Bro Morgannwg University Health Board Cwm Taf Health Board Cellnovo TrakCel EKF Diagnostics Huntleigh Healthcare Clinithink Chromogenex Technologies
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
Life science is in our blood Life science branding is important to us. It’s our life blood. Creating compelling experiences through digital and print mediums is at the heart of what we do. We can inject new life into tired brands, reinforce existing brands or create powerful new ones. Give us a call or visit our website to see how we could improve your message and create brands that will get your blood pumping.
BRANDING. DESIGN. PRINT. WEB. SPECIALISTS www.teamworksdesign.com
57
2014 Y O U R
S T E R I L E
S I N G L E - U S E
S O L U T I O N
W I T H O U T
C O M P R O M I S E
November
4th 17th - 18th 2nd - 6th Once used. Workflow improves. 8th American Association of Pharmaceutical Scientists Annual Meeting & Symposium San Diego, USA
The International Telecare & Telehealth Conference 2014
UK HealthTech Conference 2014
Cardiff, UK
Newport, UK
25th - 26th
Bio-Europe 2014
11th Annual bioProcessUK Conference
Frankfurt, Germany
Liverpool, UK
South East Wales Academic Health Science Partnership Conference
5th - 6th
25th
9th
3rd - 5th
Innovate UK 2014 London, UK
12th - 15th
ABHI Annual Regulatory Conference London, UK
Düsseldorf, Germany
December
13th
2nd - 4th
Cambridge, UK
14th
Genesis 2014 Conference: Gathering the right evidence for the right outcome London, UK
Medica Tradefair
PCI Event: Too Hard to Handle - EU Clinical Trials Seminar
Cardiff, UK
CPhI India
Mumbai, India
3rd - 4th
BIOMEDevice San Jose California, US
9th - 10th
ABHI: Sterilisation & Microbiology Standards Solihull, UK
10th
MediWales Innovation Awards 2014
Cardiff, UK
UKTI: ExploreExport Cardiff, UK
Life Science Event Calendar 2014-15 ®
58 t +44 (0) 1792 797 910 e info@dtrmedical.com w www.dtrmedical.com
Visit us at Hall 16 F42
2015
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
January
February
March
12th - 15th
1st - 6th
3rd - 4th
Connecting G Protein-Coupled Receptor Mechanisms to Physiological Functions 2015 Ventura, US
London, UK
JP Morgan Biotech Showcase 2015 San Francisco, US
21st - 22nd Pharmaceutical Microbiology London, UK
23rd - 26th Arab Health
Dubai, United Arab Emirates
27th - 28th
4th Annual Clinical Development and Trials Asia Congress Shanghai, China
27th - 28th
5th Annual Pharma R&D Asia Congress Shanghai, China
Molecular Pharmacology:
9th - 10th
MEDTEC UK
3rd - 4th
8th Annual European Life Sciences CEO Forum
HVM Graphene
Zurich, Switzerland
10th - 12th
BioWales
Cambridge, UK
Digital Health Assembly Open Innovation Conference Cardiff, UK
11th
ABHI: Export Seminar: A Focus on China London, UK
2 0 1 4 - 1 5
4th - 5th Cardiff, UK
8th - 11th
Bio-Europe Spring Paris, France
21st - 23rd
Medical Fair India New Delhi, India
18th - 19th
Life Sciences Israel Tel Aviv, Israel
25th - 26th
UKTI: USA Distributors Bootcamp London, UK
December 4th 2014
January 23rd 2015
Cardiff
Dubai
UK HealthTech
Arab Health
February 10th-12th 2015
Digital Health Assembly Cardiff
59
thesummary 5th - 7th
April
May
21st - 23rd MEDTEC Europe
Africa Health 2015
22nd - 24th
19th - 21st
Stuttgart, Germany
22nd
4%
UKTI: Society of Advanced Woundcare Mission Texas, US
23rd
Asia Biotech Invest 2015 Hong Kong
3%
19th - 22nd Hospitalar 2015 São Paulo
June
Anglonordic Life Science Conference
15th - 18th
28th – 30th
Philadelphia, US
London, UK
NAIDEX National 2015 Birmingham, UK
25% 71%
Bio International Convention
24th – 26th CPhI China
29th – 30th
Med-Tech Innovation Expo Coventry, UK
E M P LOY M E N T L E V E L S
Shanghai, China MEDICAL TECHNOLOGY AND DIAGNOSTICS
Tokyo, Japan
W E L S H L I F E S C I E N C E S E C TO R S DATA
CPhI Japan
Johannesburg, South Africa
68%
March 4 – 5th 2015
BioWales 60
Cardiff
5%
MEDICAL BIOTECH
5%
INDUSTRIAL BIOTECH
PHARMACEUTICALS
Popular Dates 2014-2015 19%
April 21 – 23rd 2015
June 15-18th 2015
Stuttgart
Philadelphia
Europe C O M P A N I E SMEDTEC BY S EC TO R
BIO International
M E D I W A L E S
A N N U A L
R E V I E W
A N D
D I R E C T O R Y
2 0 1 4 - 1 5
+ WWW.PDRONLINE.CO.UK
MEDICAL DEVICE DESIGN ROBUST PRODUCT + ENGINEERING DESIGN USABILITY + HUMAN FACTORS STUDIES INTERACTION + USER INTERFACE DESIGN ADVANCED RAPID PROTOTYPING LOW VOLUME RAPID MARKET ENTRY MANUFACTURE MANUFACTURING + NPI SUPPORT IN HOUSE CAPABILITY DEVELOPMENT KNOWLEDGE TRANSFER
THE NATIONAL CENTRE FOR PRODUCT DESIGN + DEVELOPMENT RESEARCH
PDR WESTERN AVENUE CARDIFF UK CF5 2YB
T +44 (0)29 2041 6725 F +44 (0)29 2041 6973 E INFO@PDRONLINE.CO.UK
61
+ WWW.PDRONLINE.CO.UK
We developed a gynaecological training simulator that improves performance on the bottom line
thesummary
E M P LOY M E N T L E V E L S
W E L S H L I F E S C I E N C E S E C TO R S DATA
4%
3%
25%
Ever had a brilliant idea that you know could succeed... if only someone could turn it into a commercial reality?
5%
19%
Whether it’s a gynaecological training simulator or a bioluminescent water monitor, we make it possible.
5%
Visit us in Hall 16, Stand F32 Come and have a chat with Claire who has come to Medica to discuss your project ideas.
C O M PA N I E S BY S E C TO R
62
MEDICAL BIOTECH
fascinated by the challenges presented by imaginative clients and offers a complete skill set for product development.
We combine these capabilities with creativity, experience and absolute problem solving intelligence to deliver solutions that are innovative, commercial and practical.
INDUSTRIAL BIOTECH
PHARMACEUTICALS
It’s what we do. As one of the UK’s leading technology and innovation companies we turn brilliant ideas into commercial realities. Our talented and friendly in-house team is
MEDICAL TECHNOLOGY AND DIAGNOSTICS
71%
68%